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Malaria is endemic in many parts of the world, including regions of sub-Saharan 
Africa, South America, and parts of Asia. Currently, there are five species known to cause 
malaria in humans: P. falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi. Among 
them, P. knowlesi is a zoonotic parasite restricted to mostly South East Asia. According to 
the World Malaria Report from 2018 1, these five species were responsible for nearly 219 
million infections, resulting in an estimated 435,000 deaths related to malaria in 2017. One 
of the milestones set by the World Health Organization (WHO) Global Technical Strategy 
is the elimination of malaria in at least ten countries that were malaria endemic in 20151. 
 Malaria control strategies still rely on traditional vector control efforts, such as 
indoor residual spraying and the use of insecticide-treated bednets along with case 
management, using proper diagnosis and treatment. However, there has been an increase 
in the number of malaria infections that are resistant to first-line therapies, such as 
artemisinin combination therapies (ACT) 1. Reports of resistance are especially high in 
parts of South East Asia 1. In order to combat the spread of resistance, it is essential to 
monitor the movement of drug-resistant parasites using molecular markers of resistance 
and adopt appropriate treatment strategies. Recent progress in genomics research has 
helped to identify genetic markers associated with resistance and use them to understand 
the molecular mechanisms involved in the development of resistance, study the 
evolutionary dynamics of resistance, and track the spread of resistance. 
 The increasing throughput and decreasing costs of Next Generation Sequencing 
(NGS) technologies enable large-scale surveillance of outbreaks and spread of drug 
 xiii 
resistance. However, there is a lack of standardized tools for the analysis of the large 
amounts of data produced from NGS sequencers, especially in a public health context. The 
work presented in this thesis describes solutions for the surveillance of outbreaks of 
infectious diseases and the spread of drug resistance on a global scale. The goal of this 
dissertation is to develop fast and efficient algorithms that can be scaled according to the 
computational resources available. 
 Genomic clustering is a commonly used technique to understand the relatedness of 
isolates from outbreaks of infectious diseases. Traditional methods used to estimate genetic 
distances between organisms use pairwise or multiple sequence alignment to identify 
regions of similarity. Significant advances have been made in alignment-based genomic 
clustering techniques over the past decade, however, they still rely on computationally 
intensive processes. In an effort to overcome this challenge, I explored the use of 
alignment-free methods for genomic clustering, which often improves the performance of 
an algorithm by an order of magnitude. 
 Alignment free methods usually start with breaking genomic sequences into 
overlapping fragments of the same length, called k-mers. For example, if the size of the 
fragment (k) is 31, we would identify and store all substrings of length 31 from the genomic 
data. Each substring and its corresponding frequency in the genome can be used as a proxy 
for genomic diversity. The method I propose in Chapter 3, Gentoo, uses the overlap of k-
mer sets from sequencing read data of two organisms to estimate their relatedness. This 
information can be used to cluster isolates in an outbreak. This new method provides a 
more scalable and accurate platform for genomic clustering as compared to other 
established techniques and can significantly impacts genetic epidemiology in public health. 
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Working with the Malaria Branch at the Centers for Disease Control and Prevention 
(CDC), I realized the need for more robust methods to track the spread of drug resistance. 
The development of drug resistance in a pathogen is usually a result of the selective 
pressure due to treatment. Ineffective or incomplete treatment and control strategies end 
up selecting pathogens that have developed mutations conferring resistance to that drug 
treatment. Drug resistance can severely affect the epidemiological effort to contain the 
spread of infectious diseases such as malaria. 
Through treatment efficacy studies (TES) and genome-wide association studies 
(GWAS), molecular markers associated with resistance to antimalarial drugs have been 
identified. These markers are generally Single Nucleotide Polymorphisms (SNPs) in 
essential genes involved with binding or efflux of drug molecules. Considering this, I 
developed a framework to identify the prevalence of SNPs associated with drug resistance 
from NGS data. This framework was adopted by The Malaria Branch at CDC for the 
surveillance of antimalarial drug resistance. 
Identifying SNPs from sequencing reads involves aligning the reads against a 
reference genome and calling SNPs from the alignment using variant calling algorithms. 
In the past decade, many different algorithms have been developed for the identification of 
SNPs from sequencing data. However, recent publications have shown that variant calls 
made by different algorithms on the same dataset are not always the same. Relying on a 
single variant calling methodology makes it hard to distinguish between true variants and 
sequencing errors. Commonly used variant call filtering techniques rely on organism-
specific, population-scale databases to identify true variant calls. Population level 
information, however, is not available for all organisms. To address this concern, in 
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Chapter 4, I describe a consensus-based variant calling framework called NeST, which 
implements multiple standard variant calling pipelines and generates a consensus variant 
call. NeST provides a framework enabling the identification of high confidence variant 
calls and overcomes the inherent biases of the statistical models implemented in existing 
methodologies. The consensus framework also provides a metric to identify true variants 
from sequencing reads when standard variant filtration techniques cannot be utilized. 
NeST implements a scalable consensus variant calling framework that accurately 
identifies high confidence variant calls associated with drug resistance. NeST forms the 
foundation for the development of a surveillance system to track the global spread of drug 
resistance in malaria at the CDC. 
The following chapters will describe the current state-of-the-art and the novel 
improvements developed through this research towards improving genetic epidemiology 




CHAPTER 1. AN INTRODUCTION TO GENOMICS IN MALARIA EPIDEMIOLOGY 
1.1 Abstract 
Malaria is endemic in many parts of the world, including regions of sub-Saharan 
Africa, South America, South Asia, and South East Asia. Currently, five known species 
cause malaria in humans: P. falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi. 
Among them, P. knowlesi is a zoonotic malaria parasite with transmission localized to 
South East Asia. According to a World Health Organization (WHO) report from 2018 1, 
these five species were responsible for nearly 219 million infections, resulting in an 
estimated 435,000 deaths related to malaria in 2017. One of the 2020 milestones for the 
WHO Global technical strategy for malaria 2016-2030, is the elimination of malaria in at 
least ten countries that were malaria endemic in 2015 1. The development of novel 
molecular tools that can improve the detection of various Plasmodium species and monitor 
the spread of drug resistance in P. falciparum, will help to improve surveillance, and 
facilitate malaria control and elimination goals. The advances of Next Generation 
Sequencing provides a cost-effective solution for large-scale surveillance of drug 
resistance using molecular markers of resistance. However, there is a need for standardized, 
scalable frameworks for analysis of the vast amount of information generated from NGS 
studies. The methods described in this work propose two novel algorithms for the accurate 





1.2 Malaria parasites and their life cycle 
Malaria is a disease caused by infections from parasites of the Plasmodium genus. 
Five species of the Plasmodium genus are known to cause malaria in humans, namely 
Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale and 
Plasmodium knowlesi. Malaria due to P. knowlesi is a zoonotic form of malaria and is 
known to be an important contributor to malaria in humans living in South East Asia. 
Being a vector borne disease, malaria infections spread through bites from female 
Anopheline mosquitoes. The sporozoite is released into the human blood stream when the 
female Anopheles mosquitoes take a blood meal. The sporozoites then make their way to 
the liver, where they infect the hepatocytes. The transport of the sporozoites to the liver 
takes about 1-3 hours. The sporozoites that fail to enter the bloodstream are destroyed by 
the host immune system 2. Once the sporozoites have infected the hepatocytes, they start 
to divide mitotically and transform into a schizont. This process takes about 2-10 days. At 
the end of the liver stage, up to 40,000 merozoites per infected hepatocyte are released into 
the bloodstream. 
In cases of malaria caused by P. vivax and P. ovale infections, some parasites enter 
a dormant phase during the liver stage of infection to form a hypnozoite. They can remain 
in this dormant stage for years. Thus, for infections caused by P. vivax and P. ovale, there 
can be a recrudescence of the disease years after the first infection. 
The release of the merozoites into the bloodstream marks the start of the asexual 
blood stage of the parasite life cycle. These merozoites quickly invade erythrocytes. Upon 
invading the erythrocyte, merozoites undergo several rounds of asexual reproduction to 
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form 16-32 merozoites over a period of 48 hours, especially with P. falciparum and P. 
vivax infections. The maturation cycle varies from 24 hours (P. knowlesi) to 72 hours (P. 
malariae). When the mature schizonts rupture, newly formed merozoites are released to 
infect more red blood cells.  
Some of the asexual blood-stage parasites differentiate into the male and female 
sexual stages of the parasite development called gametocytes. The gametocytes have 
varying times of maturation, based on the species of Plasmodium involved. In P. 
falciparum infections, the gametocyte takes about 8-10 days for maturation. The mosquito 
ingests gametocytes during the blood meal. The ingestion of the gametocytes marks the 
beginning of the sexual reproduction stage of the parasite's development in the vector. 
Male and female gametocytes fuse and undergo fertilization to form a diploid zygote. 
The zygote then develops into ookinetes and then into oocysts in the mosquito midgut. 
Oocysts maturation again varies in time between different species of Plasmodium family. 
In P. falciparum, this period spans about 11-16 days, at which point the oocysts burst, 
releasing infectious sporozoites that travel to the salivary gland of the mosquito. 
Sporozoites from the salivary glands can re-infect human hosts during a blood meal and 





Figure 1.1: Stages of the Plasmodium life cycle. Human infection begins with the delivery of 
sporozoites by the bite of an infected female Anopheles mosquito during a blood meal. These sporozoites 
migrate to the liver, via the bloodstream and infect hepatocytes. Following a phase of asexual replication, 
they develop into merozoites. Merozoites are released into the blood and invade the red blood cells. The 
parasite forms the ring stage and subsequently develops into trophozoite and schizont stages. The 
schizont burst to release more merozoites, and this forms the asexual blood stages of the parasite. A 
small percentage of the ring form parasites differentiate into gametocytes and taken up by the mosquito 
during a blood meal. The gametocytes travel to the midgut of the mosquito and undergo sexual 
reproduction to form a zygote, which matures into an oocyst. The oocysts burst to release sporozoites 




1.3  Burden of Malaria 
The World Malaria Report of 2018 estimated that there are 219 million annual cases 
of malaria worldwide. Though there was a reduction in the number of cases of malaria 
reported in 2017, as compared to 2010, data between 2015 and 2017 show that there has 
not been a significant reduction in the number of cases reported worldwide 1. 
The majority of cases reported in 2017 were from the African region (92% of 
reported cases), with the South East Asia region accounting for 5% of the cases and the 
Eastern Mediterranean region accounting for about 2% of the cases. Nearly half of the 
malaria burden in the world is borne by five countries, namely, Nigeria, the Democratic 
Republic of the Congo, Mozambique, India, and Uganda. While India saw a 24% decrease 
in the rate of incidence over since 2016, Nigeria, Madagascar and the Democratic Republic 
of the Congo, all reported an increase in the number of cases reported by over half a million 
cases across each country. 
Transmission rates of malaria vary across the world due to many different factors. 
Transmission intensity ranges from a few infectious bites/year (low transmission areas) to 
several hundred infectious bites/year (holoendemic areas). The transmission rates play a 
crucial role in the manifestation of the disease and the development of natural immunity. 
In regions with high transmission, immunity to clinical malaria develops typically in the 
first five years of life. The most common manifestations of severe malaria include cerebral 
malaria, severe malarial anemia and respiratory distress in high endemic areas 2. 
In regions of low transmission rates, such as South East Asia, severe malaria is not 
restricted to children. In low transmission areas, the development of host immunity takes a 
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long time (until adulthood), and therefore severe malaria can be observed in children and 
adults. In addition to cerebral malaria and severe malarial anemia, malaria complications 
may include renal and hepatic dysfunction and multiple system disorders contributing to 
death5. 
Furthermore, pregnant women are more vulnerable to malaria than their non-
pregnant counterparts. The principal manifestation of malaria during pregnancy can vary 
depending upon the pre-existing immunity. In low transmission regions with limited 
immunity against malaria, pregnant women can experience severe consequences due to 
malaria, including cerebral malaria, severe anemia, hypoglycemia, abortion, and stillbirth. 
On the other hand, in areas with high transmission of malaria, pregnant women rarely 
experience the severe complication of malaria due to pre-existing immunity. However, in 
this region malaria infection in pregnant women leads to the development of anemia and 
low birth weight babies2. 
The number of deaths due to malaria have decreased from 451,000 deaths in 2016 to 
435,000 deaths in 2017. It is important to note that young children (under the age of 5) 
especially in Africa, remain a major susceptible group accounting for 266,000 deaths 
(61%) associated with malaria1. 
As there are no highly efficacious vaccines against malaria, vector control and case 
management, through accurate diagnosis of malaria and drug treatment, remain major 




1.4 Vector Control  
Vector control mainly focuses on the mosquito, Anopheles species, that are involved 
in the spread of the parasite. The most widely adopted method for vector control across the 
world has been Insecticide Treated Nets (ITN). According to WHO, half of the population 
at risk of malaria infections had access to ITNs in the year 2017. Another standard method 
for vector control is Indoor Residual Spraying (IRS), which involves spraying insecticides 
indoors 1. Studies have shown that both of these preventive methods have been highly 
effective at reducing the risk of malaria infections in regions with endemic malaria 6,7. 
With the advent of gene-editing technologies such as CRISPR-Cas9, researchers 
have also been working on introducing “gene drives” into mosquitoes to prevent the 
proliferation of the vector, and in turn, control the spread of malaria. In brief, these methods 
rely on identifying regions in the mosquito genome that confer sterility; a CRISPR-Cas9 
gene drive is introduced in these regions to modify the gene conferring sterility in the 
mosquito8,9. Another candidate target for the gene drive is the mechanisms that allow for 
the parasite to complete its life cycle within the mosquito10. The mechanism to modify the 
gene associated with sterility or parasite uptake is built into the mosquito genome through 
the gene drive; this method can ensure that these genetic modification are carried across 
many generations, with the potential to cause the extinction of the species capable of 
harboring the malaria parasite10,11. While this approach provides an interesting mechanism 
for vector control, the efficacy and ethics involved in vector control are beyond the scope 




Figure 1.2: Countries with indigenous cases of malaria in 2000 and their status in 2017. Countries that reported no indigenous cases in the past 
three consecutive years are classified as malaria free. All WHO countries in the European Region report zero indigenous cases in 2016 and 2017. 
China and El Salvador report no indigenous cases in 2017. Source: World Malaria Report 2018. 
9 
 
1.5 Malaria vaccines 
Another major area of research for the prevention of malaria is the development of 
vaccines. With significant investments in malaria vaccine development research in the past 
several decades, a recombinant vaccine that incorporates immunogenic epitopes of the 
circumsporozoite protein, a sporozoite surface protein, called RTS,S vaccine has been 
developed and tested extensively in clinical trials against P. falciparum infection. The 
vaccine efficacy report for RTS,S is 39%. Although the efficacy of this vaccine is low, it 
is argued that combining the partial protective effect of this vaccine along with traditional 
malaria control methods can reduce the adverse effects of malaria12. Another vaccine that 
involves the use of attenuated sporozoites against P. falciparum is in clinical trials12. In 
experimental studies, including human volunteer studies, attenuated sporozoites have 
shown higher efficacy of protection when compared to the RTS,S vaccine. However, the 
success of this vaccine remains to be tested in future clinical trials. 
 
1.6 Case management methodologies for malaria 
1.6.1 Diagnosis of Malaria 
Malaria infection status can be diagnosed using various methods. The microscopic 
examination of Giemsa stained blood smears for the presence of blood-stage parasites is 
one of the most widely adopted methods for malaria diagnosis13. Microscopic diagnostic 
capacity is limited, especially in Africa. Therefore, immunochromatographic commercial 
tests that detect one or more of the three parasite antigens, histidine rich protein 2 (HRP2), 
10 
 
aldolase, and parasite lactate dehydrogenase (pLDH), have been widely used for 
diagnosis14. Molecular tests that use PCR based methods are also available, but their use is 
restricted to research purposes and in reference laboratories for confirmation of diagnosis 
when required. The WHO policy requires confirmation of malaria diagnosis before 
treatments can be administered. 
1.6.2 Drug treatment 
Quinine was one of the first antimalarial drugs used for treatment. Subsequently, at the end 
of World War II, chloroquine became available for malaria treatment15. This was one of 
the cheapest and most effective drugs used against malaria for many years. As widespread 
resistance to chloroquine became established globally, sulphadoxine-pyrimethamine (SP) 
was introduced for primary treatment of malaria. Unfortunately, resistance to SP developed 
faster than chloroquine, and it became ineffective for the primary treatment of malaria4. 
However, this drug is still widely used for the prevention of malaria in pregnant women 
and seasonal malaria prevention15. When it became clear that widespread resistance to both 
chloroquine and SP had been established in most endemic countries, the WHO introduced 
artemisinin combination therapy (ACT) for malaria treatment15. This new drug policy was 
implemented first in Cambodia in 2000 and Peru and Venezuela in 2001. Subsequently, 
from 2004, other African countries adopted ACT for primary treatment of malaria. 
 The ACT combines a short-acting drug (half-life 1-2h) and a partner drug with a 
long half-life. Artemisinin reduces the initial parasite biomass by 95% in 2 days after 
treatment, and the partner drug eliminates any remaining parasites4. Monitoring for the 
continued efficacy of antimalarial drugs is a key strategy for making sure ACTs are 
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working as expected in clearing parasites in infected people. There are currently five 
different ACT combinations, such as artemisinin plus lumefantrine, amodiaquine, 
piperaquine, mefloquine, SP, and pyronaridine. Although it was hoped that the emergence 
of resistance to ACT would take longer as two drugs are used, partial resistance to 
artemisinin was reported as early as 2008 in Cambodia16. Recent studies indicate the 
development of resistance to artemisinin as well as for partner drugs leading to ACT 
resistance in Cambodia17. These developments highlight the importance of continued 
monitoring of drug resistance in all malaria endemic countries. 
1.6.3 Monitoring drug resistance in malaria 
The WHO recommends conducting periodic drug therapeutic efficacy studies (TES) in 
endemic countries, every 2-3 years, to confirm the efficacy of ACTs. The guidelines 
recommend that drug treatment must lead to the clearance of parasites and no 
recrudescence (90% or more patients enrolled must remain parasite free) within the 
observation period (day 28 for most ACTs and day 42 for dihydroartemisinin plus 
piperaquine).  When there is less than 90% efficacy of treatment, resistance is suspected, 
and further studies must be performed to confirm the resistance. The WHO recommends a 
change of drugs when resistance is confirmed18. 
 In addition to TESs, in vitro drug sensitivity of parasites has been used as a 
complementary method for confirming resistance. This assay is performed by culturing P. 
falciparum parasites in the presence of a varying concentration of drugs for 2 to 3 days and 
determines the minimum concentration of drug required to kill 50% of the parasites (IC50). 
The IC50 of drugs increases several-fold when parasites develop drug resistance. It has 
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been found that resistance to artemisinin leads to the arrest of P. falciparum parasites in 
the early ring stage and this phenotype is referred to as ring-stage survival assay (RSA) 
which has been found to correlate with drug resistance17. This type of assay requires 
extensive laboratory capacity in drug trial sites, and it is performed only in some countries5. 
1.6.4 Molecular markers of drug resistance 
Development of drug resistance leads to genetic changes in one or more genes that are 
involved in drug killing pathways (Table 1.1). Identification of these mutations can help 
identify resistant parasites and can be used as a tool for monitoring the spread of drug 
resistant parasites. 
The Plasmodium falciparum Chloroquine-Resistance Transporter gene (PfCRT), 
located on chromosome 7, plays a crucial role in the development of resistance to 
Chloroquine and Piperaquine. The gene encodes for a drug effluxor protein located on the 
food vacuole. Chloroquine disrupts the mechanisms through which free haem in the food 
vacuole is converted to the polymer hemozoin. Mutations in codon 76 (K to T) of the 
PfCRT have been known to confer resistance to chloroquine15,19–22. 
While structurally piperaquine is similar to chloroquine, it has been reported to 
work against parasites that have PfCRT mutations that confer resistance to chloroquine. 
There have also been studies which report that the presence of the mutations PfCRT: C101F 
in a chloroquine-resistant population, can lead to piperaquine resistance while rendering 
the parasite susceptible to chloroquine treatment23–25. Therefore, different mutations in 
PfCRT regulate resistance to chloroquine and piperaquine.
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Table 1.1: Common antimalarial drug and genetic markers associated with drug resistance in P. falciparum. crt, chloroquine-resistance 
transporter; cytb, cytochrome b; dhfr, dihydrofolate reductase; dhps, dihydropteroate synthase; mdr1, multidrug resistance protein; pfkelch13, P. 
falciparum Kelch 13; plm2, plasmepsin 2. * Drug used in artemisinin-based combination therapy; Ψ Antimalarial drug used alone or in combination 
with molecules other than artemisinin derivatives.  
Chemical  
 class 
Common name Targeted parasite stage 
Genetic marker for drug 
resistance in P. falciparum 
Sesquiterpene lactone 
endoperoxide 
Artemisinin* All parasite stages pfkelch13 
Artesunate* All parasite stages pfkelch13 
Artemether* All parasite stages pfkelch13 
Dihydroartemisinin* All parasite stages pfkelch13 
4 - Aminoquinolines 
Chloroquine ψ Blood stages (trophozoite and schizont) pfcrt 
Amodiaquine* Blood stages (trophozoite and schizont) pfcrt, pfmdr1 
Piperaquine* Blood stages (trophozoite and schizont) pfplm2, pfcrt 
Pyronaridine Blood stages (ring, trophozoite and schizont) pfcrt 
Naphthoquine* Blood stages (trophozoite and schizont) Unknown 
Amino alcohols 
Quinine ψ Blood stages (trophozoite and stage I to III gametocytes) pfcrt, pfmdr1 
Mefloquine* Blood stages (trophozoite and schizont) pfcrt 
Lumefantrine * Blood stages (trophozoite and schizont) pfcrt, pfmdr1 
Halofantrine ψ Blood stages (trophozoite and schizont) pfcrt, pfmdr1 
8 – Aminoquinoline Primaquine* Blood (gametocyte) and liver (schizont) forms Unknown 
Antifolates 
Pyrimethamine* Blood and liver schizont and mosquito stage (oocysts) pfdhfr 
Sulfadoxine * Blood and liver schizont pfdhps 
Proguanil* Blood stages (schizont and gametocyte) and liver schizont pfdhfr 
Naphthoquinone Atovaquone ψ Blood stage (schizont and gametocyte) and liver schizont pfcytb 
Antibiotics 
Clindamycin ψ Blood stages Apicoplast target 
Doxycycline ψ Blood stages Apicoplast target 
Tetracycline ψ Blood stages Apicoplast target 
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 The antimalarial drugs sulfadoxine and pyrimethamine affect the folate pathway in 
the parasite, by inhibiting two enzymes, Plasmodium falciparum dihydropteroate synthase 
and Plasmodium falciparum dihydrofolate reductase, encoded by the gene PfDHPS and 
PfDHFR present on chromosome 4 and 8 respectively of the P.  falciparum genome (Figure 
1.3). Mutations in the catalytic sites of these enzymes, and amplification of the two genes 
have been known to confer resistance to sulfadoxine-pyrimethamine in endemic 
regions15,26–30.  
The naphthoquinone drug atovaquone, in combination with the proguanil, is 
administered to people traveling to malaria-endemic countries. The drug combination 
works by disrupting the mitochondrial membrane potential by targeting the mitochondrial 
gene PfCYTb. Mutations in PfCYTb have been found to be associated with resistance to 
atovaquone31,32. Resistance to proguanil has been associated with some mutations in 
PfDHFR15,31–33. 
Figure 1.3: The pathways involved in the action of anti-malarial drugs and the molecular 
markers that affect the resistance. Source: Blasco et al. 2017. 
15 
 
The Plasmodium falciparum multidrug resistance (PfMDR1) protein is a xenobiotic 
drug efflux protein that is associated with resistance to many classes of antimalarial drugs 
(Table 1.1). The gene encoding the food vacuole protein, PfMDR1, is present on 
chromosome 5, and the primary mechanism involved with resistance is through 
amplification and mutations within the coding region of the gene5. Copy number variations 
associated with PfMDR1 have been known to confer resistance to many antimalarial drugs 
including mefloquine, lumefantrine, quinine, and artemisinins34–37. Coding mutations in 
PfMDR1 such as N86Y, Y184F, C0134S, N1042D, and D1246Y have also been associated 
with drug resistance38–40. 
Table 1.2: Candidate and validated resistance mutations in the K13 BTB/POZ and propeller 
domain. 
Validated Candidates/ Associated 
F446I P553L P441L G538V 
N458Y R561H G449A V568G 
M476I C580Y C469F P574L 
Y493H  A481V F673I 
R539T  P527H A675V 
I543T  N537I  
The main gene associated with resistance to artemisinin compounds is the PfK13 
gene. The gene is located on chromosome 13. This gene is composed of six kelch domains, 
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and mutations in this region has been found to be associated with delayed parasite 
clearance15. Table 1.2 lists some of the confirmed resistance markers found in PfK13. 
Presence of these mutations at allele frequency > 10% in a given geographical site is 
considered to be indicative of suspected artemisinin resistance and WHO recommends 
further investigation to confirm resistance41. The exact mechanism by which PfK13 
influences resistances against artemisinins remains elusive.  
Molecular markers associated with resistance are useful for tracking drug-resistant 
parasite populations. Moreover, by studying the genetic variations around drug-resistant 
markers, one can understand the evolutionary history of drug-resistant parasites. Figure 1.4 
shows how resistance to chloroquine (Red arrows), and pyrimethamine (Black arrows) 
spread globally and describes how ACT resistance is evolving (box) in South East Asia4. 
From microsatellite-based haplotypes alleles flanking resistant genes, it was found that 
there were only 4 to 5 founding populations of chloroquine-resistant PfCRT and they 
contributed to the global spread of chloroquine resistance. Two such lineages originated in 
South America, and they spread across the continent. Two lineages from South East Asia 
contributed to the spread across Asia as well as Africa. Similarly, pyrimethamine resistant 
PfDHFR alleles also spread across the globe. 
 
1.7 Progression from Sanger sequencing to Next Generation Sequencing (NGS) for 
molecular surveillance 
As described in the previous section, molecular characterization of resistance 
markers is crucial for monitoring resistant parasites as well as for understanding various 
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aspects of resistance, including evolutionary history and the spread of resistant parasites. 
Sanger sequencing is the most widely adopted method across public health labs for the 
characterization of resistant parasites. The cost of analysis using Sanger sequencing, 
coupled with low throughput and reduced sensitivity at detecting sequence variations at 
low frequency in mixed infections, make it unsuitable for large-scale surveillance of drug 
resistance. Advances in NGS methods and the use of targeted genome sequencing 
approaches has made it very cost-effective to sequence multiple resistance genetic markers 
in a multiplexed manner, allowing for the identification of minor allele mutations in the 
population at very low frequency. In this thesis, I develop NGS methods for characterizing 
six primary P. falciparum drug-resistant genes and develop a bioinformatics pipeline to 
identify well-characterized mutations as well as new mutations in test samples. 
 
1.8 Next Generation Sequencing (NGS) solutions for malaria epidemiology 
The improvements in the accuracy of NGS technologies have enabled the use of genomics 
in better understanding the epidemiology of malaria. In the early days of sequencing, 
assessments of molecular markers for malaria relied on low-throughput Sanger 
sequencing-based or array-based protocols to identify specific mutations within samples42–
44. The decreasing cost of NGS analysis enables large-scale genomic studies to understand 
linkage disequilibrium, identification of markers involved in pathogenesis, and 




Figure 1.4: Emergence and spread of P. falciparum resistance to chloroquine, pyrimethamine, and artemisinin derivatives. Resistance to 
chloroquine emerged at multiple sites and spread across the world (black arrows), due to the selective pressure on PfCRT mutant alleles. Resistance to 
pyrimethamine emerged in South East Asia and South America. Resistance to pyrimethamine due to a triple mutation in PfDHFR spread to Africa (red 
arrows). Pyrimethamine-resistant PfDHFR mutations independently emerged in Africa. Resistance to artemisinin derivatives were driven by mutant 




 A robust infrastructure needs to be established, one that allows researchers to access 
and explore these datasets. The malaria research community has been very active at 
establishing frameworks for malaria data exploration through the concentrated efforts of 
various consortiums. The Worldwide Antimalarial Resistance Network (WWARN) 
consortium, established with the support of the Bill and Melinda Gates Foundation in 2009, 
has developed an online framework to evaluate the efficacy of treatment regimens against 
malaria, track the prevalence of antimalarial drug resistance, and provide a framework to 
inform research on the development of new drugs to combat malaria46. 
Another essential resource for malaria genomics has been PlasmoDB47. PlasmoDB 
is a functional database for genomic data, transcript and protein expression data, functional 
annotation, population genetics, and evolutionary information for Plasmodium spp. The 
information made available to the public through databases like PlasmoDB enable 
researchers to access to up to date annotations, and reference sequences. Thus, enabling 
the standardization of large-scale GWAS studies for the evaluation markers associated with 
the spread of antimalarial drug resistance, as well as the generation of accurate reference 
genomes through sequence assembly projects. 
The MalariaGen consortium provided a significant push towards adopting NGS in 
malaria epidemiology. With projects such as the Pf3k Project and the Ag100P project, 
among many others, the consortium aims to utilize Whole Genome Sequencing of Human, 
Mosquitoes and Plasmodium parasites to understand the genetic epidemiology of malaria 
better. Approaching the same problem from a different angle, investigators in the malaria 
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branch at the Centers for Disease Control and Prevention (CDC), as a part of the Malaria 
Resistance Surveillance (MaRS) project, developed an amplicon sequencing protocol, to 
track molecular markers for drug resistance. The protocol described in Figure 1.5 relies on 
Target Amplicon Deep Sequencing (TADS) to identify the presence of variants associated 
with drug resistance across five genes in P. falciparum as well as the mitochondrial 
genome. The goal of the MaRS project is to build a database of variants to study the 
prevalence of mutations conferring drug resistance, and to identify new molecular markers 
associated with drug resistance. Chapter 4 of this thesis details the NGS analysis platform, 
NeST, which is currently being used by the CDC to analyze the data generated from the 
MaRS protocol48. 
 
1.9 Algorithms to monitor outbreaks and molecular surveillance of drug resistance 
using Next Generation Sequencing (NGS). 
Building on the established frameworks for epidemiology and molecular surveillance in 
public health, in this work, I describe two novel algorithms for genomic clustering and 
molecular surveillance of drug resistance from next generation sequencing data. The two 
specific aims of the present research are: 
1. Development of algorithms for genomic clustering of NGS datasets using an 
alignment free k-mer based approach. 
2. Development of algorithms for the molecular surveillance of drug resistance from 
NGS datasets in a public health setting. 
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In the previous sections, the biological mechanisms that govern the spread of drug-
resistance in malaria were reviewed. We briefly discussed the molecular markers for drug-
resistance, including variants in key genes associated with resistance. Finally, we discussed 
the tools available for molecular surveillance in malaria.  
Chapter 2 reviews existing methods for the identification of Single Nucleotide 
Polymorphisms (SNP) from sequencing reads and proposes a new consensus-based variant 
calling framework to overcome the pitfalls of existing methods. State-of-the-art for 
genomic clustering from NGS data are also discussed here. The basis and advantages of 
using alignment-free algorithms for genomic clustering is highlighted. 
To address the first aim of this thesis, Chapter 3 outlines the alignment-free k-mer 
based algorithm, Gentoo, for genomic clustering from NGS data in a public health setting. 
The new algorithm utilizes k-mer frequencies from isolates to calculate an exact measure 
of genomic distance. Comparison against the state-of-the-art clustering algorithms 
highlights the improved resolution of genomic clustering offered by Gentoo. The utility of 
the method in understanding relatedness of isolates in a public health setting is 
demonstrated using NGS datasets from Plasmodium species and Candida auris. 
Chapter 4 describes a consensus-based variant calling framework, NeST, to address 
the second aim of this thesis. The design principles for developing a modular, scalable, 
standardized framework are described in detail here. The improved precision offered by 
the consensus framework is evaluated using in-silico datasets generated from Plasmodium 
falciparum genes. The applicability of the framework in molecular surveillance of drug 
resistance is demonstrated using P. falciparum samples isolated from imported cases of 
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malaria in the United States. Finally, the scalability of the frameworks is evaluated by 
analyzing 8,351 Mycobacterium tuberculosis isolates to identify genotypic markers for 
drug-resistance.  
Chapter V concludes this dissertation and summarizes my contributions to 




Figure 1.5: MaRS protocol workflow overview with steps indicated, along with reagents 




CHAPTER 2. VARIANT CALLING AND GENOMIC CLUSTERING 
2.1 Abstract 
DNA sequencing is the process of identifying the order of nucleotides (A, C, G, T) in a 
molecule of DNA. Knowledge of the sequence of a DNA molecule plays a crucial role in 
medical diagnosis and epidemiology. The past decade has seen a rapid evolution of DNA 
sequencing technologies from second-generation high-throughput short-read sequencing 
to third-generation long-read sequencing methods. The cost of DNA sequencing has been 
decreasing at a rate much faster than Moore’s Law (Figure 2.1). With such rapid progress, 
the incorporation of sequencing in biological sciences has been increasing rapidly. 
Figure 1.1: Cost per MB of DNA sequenced. To highlight the improvements in sequencing 
technology, the graph shows a line reflecting Moore’s Law, which states that “compute power” 
doubles every two years. Technologies that keep up with Moore’s Law are considered to be doing 
exceedingly well. The y-axis uses a logarithmic scale. The sudden drop in the cost of sequencing 





  This trend extends to public health as well; an increasing number of studies have 
been adopting Next Generation Sequencing (NGS) technologies to understand the 
molecular epidemiology of infectious diseases. A quick search of NCBI’s Sequence Read 
Archive shows that there have been over 70,000 submissions of NGS datasets just for the 
human malaria parasite Plasmodium falciparum to date. With short-read sequencing being 
the most widely used technology in malaria genomics. 
 Given the popularity of NGS, the need to develop tools and frameworks that can 
efficiently and accurately analyze sequencing data is increasing. This chapter outlines two 
methodologies frequently used in surveillance of infectious diseases, genomic clustering 
and variant calling from NGS data. The standard protocols and algorithms for each of the 
methods, their advantages and disadvantages are described in detail. Finally, the underlying 
principles behind the two new algorithms developed in this thesis and the advances offered 
by the new methods are discussed here. 
 
2.2 Variant calling from Next Generation Sequencing (NGS) data 
Variant calling is the process of identifying Single Nucleotide Polymorphisms (SNPs), and 
short Insertions and deletions (InDels) in sequencing data based on alignment of sequence 
reads to the reference genome for that species. Biologists have long relied on sequence 




 As discussed in the previous chapter, the identification of antimalarial drug 
resistance has long relied on identifying sequence variation. Before the advent of NGS, 
clinical blood samples containing parasites that displayed antimalarial drug resistance were 
inoculated into culture to isolate the resistant strain. The resistant strains were then 
sequenced at the locus associated with resistance using Sanger sequencing techniques to 
explore the genetic basis of the observed phenotype. 
 The advent of NGS technologies has enabled the surveillance of antimalarial drug 
resistance on a much larger scale and with greater accuracy. The ability to multiplex 
samples on a single sequencing run has drastically reduced the price of sequencing, making 
NGS based identification of resistance markers more accessible across the world. The main 
bottleneck is the bioinformatics frameworks available for variant calling. 
 While there are many methods available for calling variants from sequencing data, 
most of the methods developed are for model organisms, such as humans and mice. The 
error correction and filtering of erroneous variant calls rely on large-scale population 
databases that are not available for most organisms. Due to this, standard tools for filtering 
low-quality variant calls cannot be used in the context of non-model organisms. Relying 
on hard filters, based on quality and coverage of sequencing reads for the variant calls, 
makes it difficult to standardize variant calling pipelines across different studies. 
 To overcome the drawbacks associated with hard filters, it is proposed here that 
while the complexity of genomes, the presence of sequencing errors, and algorithmic biases 
from different methods can lead to erroneous variant calls, true variants in the data should 
be detected by all variant calling models given high-quality sequence data. Before the 
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methodology implemented to test this hypothesis is described, it is essential to understand 
the different steps involved in variant calling as well as understanding the models that are 
employed to detect active regions and variations using different variant calling 
methodologies. 
 The critical steps for pre-processing sequencing reads and variant calling from NGS 
datasets are described here and three widely used models for the identification of SNPs and 
InDels are discussed in detail. The methodology implemented in the current research 
project to overcome the biases of these standard models, is also described. 
2.2.1 Steps involved in variant calling 
Variant calling from raw sequencing data involves multiple steps to ensure the quality of 
the data that is being analyzed as well as the accuracy of the alignments being used to detect 
variants. 
2.2.1.1 Quality assessment and control 
Base-calling methodologies employed by sequencing platforms rely on signal processing 
to generate sequencing reads from a DNA template. The accuracy of the base call from 
sequencing is recorded as a PHRED based quality score and stored in the FASTQ files 
containing the sequencing reads. 
 The PHRED score is the negative log-score of the likelihood that the base call is 
erroneous49. The base quality score in the FASTQ files can be used to identify low-quality 
sequences and filter out sequences that do not meet a necessary threshold for analysis. A 
commonly used threshold used for quality in short-read data is Q30, or a PHRED score of 
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30, indicating a 1 in 1000 chance that the base call is erroneous — conferring a 99.9% 
accuracy for that base call. 
 Adapter contamination can be another source of sequencing error, which arises 
when the sequencer reads into the adapter sequence ligated to the DNA fragment that binds 
to the flow-cell. Adapter contamination usually occurs towards the ends of the sequencing 
reads. 
 Quality control tools trim reads with low quality regions and adapter contamination. 
If reads are trimmed beyond the acceptable length, they are discarded to prevent erroneous 
alignments or variant calls. If the sequence library is paired-ended, the corresponding 
paired reads are also discarded. The cleaned reads are ready for the next step of the analysis; 
alignment against a reference genome. 
2.2.1.2 Sequence alignment 
A crucial step in variant calling is the alignment of cleaned sequencing reads against a 
reference genome. The sequence alignment problem is well established, with multiple 
optimal solutions developed for pairwise sequence alignment. The most popular alignment 
algorithms are the Needleman-Wunsch50 for global alignment and the Smith-Watermann 
algorithm51 for local alignment. The throughput of NGS data, however, makes it inefficient 
to use these methodologies for aligning sequencing reads to a reference genome. 
 Modern sequence aligners rely on seed extension methods to identify the origin of 
a sequence read and align them accurately, introducing mismatches and gaps when 
necessary. Most aligners implement an affine gap penalty model that penalizes the 
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introduction of gaps more than the extension of gap and mismatch penalties to ensure that 
there is high confidence in any SNPs and InDels identified through sequence alignment. 
Algorithmic performance is optimized by indexing the reference genome using the 
Burrow-Wheeler Transform that allows quick access to the reference genome with minimal 
memory overhead, thus making modern read aligners highly accurate and fast52,53. 
 Each aligned read is given a mapping quality score based on the sequence quality, 
mismatches and gaps introduced, and the number of places the read mapped to, within the 
reference. A CIGAR string is used to denote the matches, mismatches, and gaps introduced 
in the sequence. Depending on the aligner used, the user can decide whether local or global 
alignment of reads is preferred, as well as how many multiple mapping instances are 
allowed for any given read. 
2.2.1.3 PCR de-duplication 
One of the steps in library preparation for many sequencing experiments is a PCR 
amplification step. This can lead to PCR-induced errors in sequence reads where the same 
fragment is over-represented in the sequence data. This exaggerates the evidence present 
for a variant or in some cases and causes over-representation of sequencing errors leading 
to erroneous variant calls. A common approach to resolve this problem is to mark or 
remove PCR duplicates from the sequence alignment files. Methods that detect PCR 
duplicates usually identify if the starts and the ends of the sequences are the same. If that 
is the case, the sequences are marked or removed from the downstream analysis. 
2.2.1.4 InDel realignment 
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Sequence aligners align reads independent of each other. Depending on sequence 
composition and sequence quality, erroneous gaps can be introduced in low complexity 
regions. InDel realignment methods overcome this bias by using the alignment of all reads 
in a given region to assess the placement of a read within the region of interest and realign 
it based on the evidence found across all alignments in that region. 
2.2.2 Variant calling 
Variant calling involves the determination of mutations, be it SNPs or short InDels from 
NGS data from any given sample. Many tools have been developed to perform variant 
calling on NGS datasets; and they can be broadly classified into three categories. 
2.2.2.1 Heuristic models for variant calling 
Variant callers implementing heuristic models rely on setting hard thresholds to filter out 
regions of low-quality or higher noise from NGS data. These thresholds need to be tuned 
for each dataset, though each tool recommends a default value accounting for the standard 
error rate from sequencing studies. Following the filtering of low-quality reads, the 
remaining read evidence is used to identify variants by means of a statistical test, such as a 
Fisher exact test (used by VarScan2, Shimmer, SOAP-snv), based on the evidence of 
reference to non-reference bases found in the samples53–55. 
 Heuristic models rely heavily on the selection of the right threshold for the filtering 
of noise from NGS data. When the appropriate thresholds are selected, these methods can 
be highly accurate at detecting low-frequency variants from NGS data. However, the 
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reliance on these threshold makes it harder to standardize across sample sets and can lead 
to erroneous calls when working with low depth datasets56,57. 
 
2.2.2.2 Probabilistic methods for variant calling 
Probabilistic variant calling methods like SAMtools58, identify the likelihood of each 
genotype combination based on the sequence evidence present. A likelihood of each 
genotype is calculated using allele counts, quality scores of each base, and alignment 
quality at each base in the genome58. A posterior probability of each genotype is calculated 
using the likelihood estimates and an established prior. Either a uniform prior can be used, 
or a prior can be determined using known population databases such as the dbSNP59. 
 The likelihood model is more accurate than heuristic methods when working with 
low depth samples. The drawback is that probabilistic perform poorly at detecting low-
frequency variants. Probabilistic methods also make assumptions of the number of possible 
genotypes in a given sample, usually assuming a bi-allelic state. The assumption of just 
two allele states, while simplifying the problem, may lead to a loss of accuracy while 
making variant calls60. Another shortcoming of the position or pileup based probabilistic 
methods is that they assume independence of bases, leading to erroneous calls when it 
comes to identifying InDels56,57,61. 
2.2.2.3 Haplotype-based methods for variant calling 
Haplotype based variant calling algorithms primarily rely on the same probabilistic 
framework as the methods mentioned earlier. However, these tools perform a local 
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assembly around regions of interest to identify SNPs and InDels. Read alignments are used 
to identify active regions with an increased likelihood of containing a mutation. Reads in 
and around the active regions are broken into substrings of length "k" or k-mers. These k-
mers are used to assemble over the active regions using a De Bruijn graph-like data 
structure. The assembled haplotypes are then used to determine the likelihood of each 
genotype within the active regions. 
 By using local assemblies over alignments, haplotype-based methods such as 
FreeBayes60 and GATK HaplotypeCaller61 can overcome errors in variant calls due to 
misalignment of reads in low complexity repeat regions in a genome. Since active regions 
or regions of interest are locally assembled into haplotypes, these methods, in theory, do 
not need to assume the ploidy or number of copies of DNA for the sample. Haplotype-
based callers also enable calling InDels with high accuracy, without the need of the InDel 
realignment step listed in the previous section56,57,61. 
2.2.3 Consensus-based variant calling 
While there are many different methodologies available for variant calling, each method 
has drawbacks and limitations when it comes to identifying variants from NGS datasets. 
The degree to which these limitations affect the sensitivity and specificity of the method 
depends on the quality of the data provided, the genomic complexity of the organism in 
question, the methodology used for sequencing, sample pre-processing, and downstream 
filtering of variant calls implemented62–64. 
 There has been extensive research done to understand and evaluate the accuracy of 
the various variant calling pipelines available62,63,65. Justin Zook et al. conducted a study 
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in which they sequenced a sample from the 1000 genomes dataset using different 
sequencing strategies and analyzed the resulting data using multiple variant calling 
pipelines to identify high-quality consensus variant calls that can be used to validate any 
given bioinformatic pipeline66. Many studies have shown the variance in the calls made by 
different variant calling algorithms, and conclude that a consensus call using the different 
algorithms can provide more accurate results60,61,63,65. 
 Considering the variance in results from the different algorithms, it is inadvisable 
to rely on a single variant calling methodology for the identification of mutations from 
NGS datasets. Moreover, since variant filtering techniques such as Variant Quality Score 
Recalibrator (VQSR) rely on the availability of population-level databases to identify the 
accuracy of variant calls, when working with lesser studied organisms such as P. 
falciparum, identification of high-quality variants depends on setting hard thresholds based 
on sequence abundance, sequence quality, and known error rates of sequencing platforms. 
Hard thresholds on sequencing characteristics, however, leads to difficulties in 
standardizing methodologies across different studies since hard thresholds need to be study 
specific. 
 An alternative method is to identify high-quality variants using consensus calls 
from multiple different methodologies. The biases built into each of the different methods 
can be reduced by considering variant calls that show consensus between different variant 
calling pipelines. In Chapter 4, a framework that incorporates three different variant calling 
algorithms is implemented and the accuracy of consensus calls at identifying high-quality 
variants associated with drug resistance in P. falciparum and Mycobacterium tuberculosis, 
is evaluated. Additionally, the design principles that go into building a scalable framework 
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for consensus calling and the impact it can have in monitoring the spread of drug resistance, 
are discussed. 
 
2.3 Genomic clustering 
The determination of the genomic similarity and transmission history of organisms has 
been a critical field of research in public health. Originally, the field relied on DNA 
hybridization techniques to identify similarities between two isolates. However, with the 
advent of sequencing technologies, new methods were developed to identify relatedness 
from sequencing data. While evolutionary analysis relies on substitution models to 
determine the evolutionary distance between organisms, methods for genomic clustering 
rely on sequence similarity to estimate the pairwise distance between two isolates. 
2.3.1 Alignment based genomic clustering 
Average nuclear identity (ANI) is the most widely accepted pairwise distance estimation 
technique for genomic data. Though there have been many implementations proposed to 
calculate ANI between two organisms67–69. The basic concept across all the implementation 
remains the same. Pairwise sequence alignment is used to identify regions of similarity 
between a reference and a query given a sequence identity threshold. ANI is calculated as 
the mean identity of all the similar fragments from the pairwise comparison of the reference 
and the query69. 
 The most commonly used alignment tools to identify pairwise sequence similarity 
has been BLASTN70. Faster algorithms such as Mummer71, BLAT72, and DIAMOND73 
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can also be used to determine sequence similarity. ANI has the advantage of being able to 
estimate relatedness from draft genomes and assembled genomes. However, the reliance 
on assembled genomes and sequence alignment reduces the scalability of ANI to large-
scale genome analysis. 
2.3.2 SNP based genomic clustering 
A commonly used alternative to ANI for the estimation of the pairwise distance between 
isolates is SNP based phylogenetic analysis. Here raw NGS data from isolates are aligned 
to a reference genome, and variant calling is performed on each isolate using methods 
described earlier in this chapter. Pairwise distance between the organisms is estimated 
based on the number of SNPs that are shared by the isolates. From the variant calling data, 
a distance matrix is generated based on the number of variants shared by two samples. This 
distance matrix can then be used to analyze how these samples cluster, using a neighbor-
joining tree74. 
 Alignment algorithms for NGS data are much faster as well as much more scalable 
than pairwise sequence alignment algorithms used for ANI. These algorithms also possess 
the added benefit of skipping sequence assembly, which can significantly reduce the time 
taken for the analysis. However, the main drawback of this method is its reliance on a well-
established reference sequence, which may not be available in many scenarios. 
2.3.3 k-mer based genomic clustering 
Many of the drawbacks of alignment-based methods can be mitigated by using alignment-
free, k-mer based techniques for estimating pairwise distance. Alignment free algorithms 
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rely on splitting up the sequencing data in overlapping fragments of the length “k” called 
k-mers. The overlapping k-mers can then be used to assess the relatedness of samples by 
considering the extent of shared k-mers between two samples. 
 Mash75 and Finch76, are both alignment-free k-mer based algorithms for the 
estimation of pairwise distance from raw NGS data. Finch used an XOR Boolean function 
to measure the pairwise distance from a k-mer occupancy matrix from the two samples. 
The determination of overlap between samples is done in memory, thus making it a 
resource-heavy process. Mash, on the other hand, utilizes a MinHash algorithm to calculate 
a Jaccard similarity score for a given sketch size and k-mer size. The sketch size determines 
how many k-mers are used to compute the overlap between the organisms. Sampling of k-
mers in MinHash based algorithms drastically reduces the memory footprint of the 
algorithm. Since the distance estimation relies on the sketch size, the Mash distance is an 
approximate value; an increased sketch size decreases the likelihood of erroneous distance 
estimation. However, this results in increased memory footprint and run time. Thus, it 
becomes necessary to find the right compromise for sketch size and resource cost. 
 Recently Jain et al.77 published a method that uses MinHash to estimate ANI 
through their implementation of FastANI. The method relies on using MinHash to enable 
the rapid alignment of sequences as previously implemented in MashMap78. The sequence 
alignments are then used to estimate ANI as per the previously discussed protocol. By 
speeding up the bottleneck of sequence alignment, FastANI provides a scalable solution 
for the estimation of ANI from assembled and draft genomes. 
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In Chapter 3, I introduce a novel alignment-free, k-mer based algorithm, Gentoo, 
for the estimation of genomic similarity of organisms. The method accepts assembled or 
draft genomes as well as raw NGS data in FASTQ format. Pairwise distance is calculated 
using the frequencies or counts of k-mers shared between the sequence datasets of an 
organism of interest. Having the ability to use raw sequencing data demonstrates its 
improved utility compared to methods like FastANI79 and ANI69. The utilization of k-mer 
counts in the estimation of pairwise distance provides a more exact estimate of distance 
compared to methods like Mash75 and Finch76. The scalability and memory efficiency of 
the algorithm to accurately cluster isolates is demonstrated using NGS data from 




CHAPTER 3. K-MER BASED CLUSTERING ALGORITHMS TO IDENTIFY 
RELATEDNESS OF SPECIES FROM WHOLE GENOME SEUQENCING DATA 
3.1 Abstract 
Improvements in short- and long-read sequencing technologies have enabled the use of 
NGS to determine the relatedness of isolates and species identification in epidemiological 
settings. Current methods for the determination of relatedness of microorganisms such as 
ANI69 and SNP-based clustering methods rely on pairwise alignments of assembled 
genomes or SNP differences between isolates when compared against a reference genome. 
While these methods are well-established, they are hard to scale and rely on well-
assembled genomes or the availability of high-quality references. While methods like 
MaSH75 and FastANI77 provide faster, scalable alternatives, they rely on probabilistic 
methods and lose sensitivity when it comes to distinguishing isolates at the species level. 
Here we propose a k-mer based reference free algorithm, Gentoo, to identify the relatedness 
of isolates from raw NGS data. In the next few sections, we will describe in detail the 
algorithm used for the pairwise distance estimation. The accuracy of clustering provided 
by Gentoo, in comparison with state-of-the-art methods, will be done using NGS datasets 
from Plasmodium spp. genomes. Finally, the utility of Gentoo in the identification of 
genomic clustering from a real-world outbreak will be evaluated using NGS samples from 
a C. auris outbreak in Colombia. Memory profiling metrics are captured to show the 





In the previous chapter, we discussed in detail the different methodologies available for 
genomic clustering. The pros and cons of each method were presented, and we touched 
upon the idea of a reference free, k-mer based scalable tool for genomic clustering and the 
considerations that go in developing such a system. In this section we detail the 
implementation of the system and its application in public health. Genomics in public 
health, especially DNA sequencing, has been mainly used to explore the diversity of 
infectious species80,81, explore sequence variations that can be beneficial or harmful to the 
organism48,82–84 and use genomic clustering to understand the epidemiological structure of 
an outbreak74,85,86. 
 Improvements in short- and long-read sequencing technologies have enabled the 
generation of well-annotated complete genome references. Recently, three large-scale 
genome projects generated complete references for different Plasmodium species and 
strains80,81,87. In each case, the knowledge of the closest known species with a complete 
genome helped with the improvement of genome assembly and annotations produced. 
While it is easy to establish the closest known relative of well-studied species from their 
phylogeny, this is a harder proposition for previously unknown or lesser studied organisms. 
The ability to generate a guide tree from NGS data could help with the identification of the 
closest known relative of any given isolate and help with the generation of complete 
genomes. 
 For evolutionary analysis, phylogenetic techniques usually consider conserved 
orthologs found across species and apply complex evolutionary substitution models to 
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arrive at the phylogeny. When dealing with epidemiological studies, looking at outbreaks 
of infectious diseases, researchers use simpler genomic clustering algorithms to quickly 
identify the species composition of a group of isolates. The most widely used method for 
grouping samples by sequence similarity is ANI69. The extent of similarity between shared 
sequences is used to estimate pairwise distance in ANI. Due to its reliance on alignments, 
ANI is hard to scale to NGS datasets. Other methods such as Mash75, use probabilistic data 
structures such as MinHash on sketches of k-mers from the genome, which serve as an 
approximate representation of the sequence content of an isolate, and estimate distance by 
calculating the extent of overlap of the k-mer sketches between two organisms. More 
recently, probabilistic data structures are being used to speed up pairwise alignments, 
allowing for the use of ANI at a larger scale77. 
 SNP-based phylogenetic methods are also commonly used to identify clusters of 
similar isolates in outbreak scenarios. The distance between samples is estimated by the 
number of SNPs that are shared by isolates against reference used74. While they can provide 
an effective assessment of the relatedness between isolates, the accuracy of the method is 
highly dependent on the presence of a complete reference. Here we propose a k-mer based 
reference-free clustering algorithm, Gentoo, to generate genetic distances from reference 
genomes, genome assemblies as well as raw FASTQ files from outbreak isolates. The 
proposed algorithm will calculate pairwise genetic distances from k-mer counts, derived 
from reference genomes as well as raw NGS data from any sequencing platform. In the 
following sections, we will highlight the accuracy of Gentoo in building the evolutionary 
tree of the Plasmodium spp. We will evaluate the effect of sequencing errors on clustering 
accuracy by generating in-silico datasets for all the 20 Plasmodium genomes. We will 
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demonstrate the scalability and utility of Gentoo in other outbreak scenarios by clustering 
isolates from a C. auris outbreak in Colombia. 
3.3 k-mer based clustering algorithm to identify the relatedness of species from 
NGS data 
Previous work at the Vannberg Lab (Finch) had evaluated the use of k-mer occupancy and 
Boolean algorithms to estimate the distances between organisms76. The previous method 
accounts for the presence or absence of a k-mer set to evaluate the relatedness. Here we 
propose a highly parallelized, low memory footprint algorithm that accounts for k-mer 
frequencies to assess the similarity between two given sets of genomic sequences. 
 Gentoo accepts reference genome FASTA files, assemblies, and raw FASTQ files. 
When provided with FASTA files, the k-mers in each contig are counted using KAnalyze88, 
by default the k-mer size is set to 31. When working with FASTQ data, the k-mer counting 
is performed with a filter to remove any k-mer with a count of less than 4. This is set to 
remove any k-mer generated from sequencing errors. 
Following k-mer counting, the files containing the list of k-mers and their counts, 
k-mer count (KC) files, can be used to calculate the similarity between samples. Given that 
the count files are numerically sorted, the algorithm scans through two KC files using a 
merge algorithm. This reduces the comparison problem to an O (N + M) problem, allowing 
us to maintain a low memory footprint. Gentoo uses the multiprocessing capability of most 
modern-day computers to spawn multiple threads of pairwise comparisons, thus reducing 
the overall run-time of analysis. 
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The metric implemented in Gentoo to evaluate the similarity of organisms is a 
weighted Jaccard distance (3.1). For each k-mer that is found in both samples, the minimum 
k-mer count is added towards the intersection set of the organisms. The maximum k-mer 
count towards the union between the two sets. If a k-mer is only found in one of the two 
organisms, the count is added towards just the union set. 
 








Finch, on the other hand, relied on k-mer occupancy to determine relatedness, i.e., 
if a k-mer is present in two genomes, it would affect the similarity index for the genomes. 
Utilizing the k-mer counts as weights will overcome the biases of considering occupancy. 
It provides a method that is aware of variation in k-mer counts (or coverage at similar 
regions) and inherently corrects for these biases by assigning a lower weight. In k-mer 
space variations such as SNPs, InDels, duplications and low-complexity repeats 
differences between organisms are also represented as differences in k-mer counts of k-
mers from the region. Gentoo uses this feature to derive a higher resolution compared to 
the previously used occupancy method while estimating the similarity between closely 
related sequences. 
All pairwise distances are stored in a distance matrix in memory. Using scikit-bio 
a neighbor-joining tree is constructed from the distance matrix. The neighbor joining tree 




The algorithm mentioned above uses a KC (k-mer count) file as input. As 
mentioned earlier, in Gentoo, we use KAnalyze88 to generate k-mer counts from FASTA 
and FASTQ files. k-mers, as the word indicates, are fragments of a genome sequence of 
length k. The process of k-mer counting involves breaking a given sequence into fragments 
using a sliding window across a genomic sequence and counting the occurrence of each k-
mer. Since NGS data can have millions of reads, this process can be highly memory 
intensive and slow. KAnalyze tries to overcome these barriers by using a divide and 
conquer method. Fundamentally, sequences are first broken into k-mers and stored in 
segment files of a pre-defined size. Once all the sequences have been broken into k-mers, 
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the segment files recursively merged and each k-mer is counted along the way. By setting 
the size of the segment file, one can control the number of k-mers that can be stored in 
memory at any given point of time and optimize for the runtime of the tool. 
 
Figure 3.1 Overview of the steps involved in k-mer counting. a) Raw DNA sequences from 
FASTA or FASTQ files. b) k-mer count tables at 4-mers for the sequence from (a) in string 
representation. c) 2-bit encoding scheme for DNA sequences. d) Integer representation of k-mer 
count tables. d) Conversion of string representation of k-mer to integer representation. 
KAnalyze also implements an integer hashing function (Figure 3.1) where each base 
of the DNA is encoded as two-bit integers. Leveraging the fact that with every k-mer we 
read, only one new base is added, KAnalyze uses a sliding window to scan across a 
sequence and generate 2-bit encoded k-mers from the sequence data. In most programming 
languages, integers occupy a fixed amount of memory, the memory footprint of strings, 
however, varies with the number of characters in the string, the total memory of a string is 
always the sum of the memory used by each character. Thus, integer encoded strings 
further reduce the memory footprint of downstream processes. While merging the 
individual k-mer segment files, KAnalyze implements a merge sort that efficiently counts 
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and sorts the numerical or lexicographically based on the output format selected. Algorithm 
1 can be applied only to sorted datasets, the sorted output from KAnalyze allows for the 
implementation of a memory-efficient algorithm for downstream processing of k-mer 
counts. 
3.4 Evaluating the accuracy of Gentoo in comparison to ANI as a methodology to 
identify relatedness of Plasmodium spp. 
3.4.1 Materials and methods 
ANI has long been the accepted standard for the determination of relatedness of organisms 
from Next Generation Sequencing data, but the reliance on completed assemblies and 
annotation hinders the scalability of the method. Probabilistic methods like Mash75 and 
FastANI77 on the other hand improve the scalability of the analysis by employing a k-mer 
based method, MinHash methodology, to speed up the analysis.  
 To evaluate the accuracy of Gentoo against these methods, 20 genomes from 10 
different species of Plasmodium studied by Rutledge et al.81 for the phylogenetic analysis 
of Plasmodium malariae were download from PlasmoDB. Nine of the twenty genomes 
were various strains of Plasmodium falciparum.  
 Further evaluation of Gentoo at estimating pairwise distances from raw NGS data, 
was done on in-silico datasets generated from the Plasmodium genomes using DWGSIM90. 
MiSeq paired-end data was simulated for all genomes with error rates of 0.01 and 0.05 
(Table 3.1), with a coverage of 30x across the genome. Since Mash and Gentoo were the 
only tools capable of estimating distances from raw FASTQ files, the trees generated by 
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Mash and Gentoo from this analysis were compared with the published Plasmodium to 
determine how the methods were able to recreate the ground truth.  
ANI values were calculated from the 20 genome FASTA files using PyANI91, a 
wrapper around the different steps involved in calculating ANI. Internally, PyANI 
implements Mummer71 to identify sequence similarity between the FASTA sequences and 
calculates ANI from sequences meeting the minimum identity threshold of 90% as 
described by Goris et al.69. 
 Mash was run using the default sketch size of 1000 and k-mer size of 21. Mash was 
run separately on the FASTA and in-silico generated FASTQ files. To generate the sketch 
from FASTQ files, the paired-end sequences for each sample were combined and a sketch 
was generated using default settings. Pairwise distances between sequences were 
calculated using Mash dist feature. 
 Gentoo index was run to generate k-mer counts from FASTA and FASTQ data. K-
mer counting on raw FASTQ files was done using KAnalyze88. All k-mers of length 31 
with counts less than 4 and lowest base quality of less than 20 were discarded. Gentoo 
cluster was run using the resulting KC (k-mer count) files as input, as described in the 
previous study, and a neighbor joining tree was generated from the pairwise distances. 
Since Finch uses the same KC files for clustering, Finch was run on the Plasmodium dataset 
using a k-mer size of 31, as well. A memory profiler was used to record run-time and 
memory utilization of each of the tools.  
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Table 3.1: In-silico datasets generated from each of the Plasmodium spp., genomes. 
Sample name Read count Error rate 
Pbrasilianum 1884594 0.01 
PlasmoDB-44_PreichenowiCDC_Genome 1446111 0.01 
PlasmoDB-44_Pfalciparum7G8_Genome 1370010 0.01 
PlasmoDB-44_PfalciparumGN01_Genome 1422907 0.01 
PlasmoDB-44_Pfalciparum3D7_Genome 1400069 0.01 
PlasmoDB-44_PvivaxP01_Genome 1744686 0.01 
PlasmoDB-44_PmalariaeUG01_Genome 2017480 0.01 
Pbrasilianum_draft 1810942 0.01 
PlasmoDB-44_PfalciparumHB3_Genome 1368882 0.01 
PlasmoDB-44_Pchabaudichabaudi_Genome 1138527 0.01 
PlasmoDB-44_PfalciparumCD01_Genome 1412870 0.01 
PlasmoDB-44_PfalciparumGB4_Genome 1409521 0.01 
PlasmoDB-44_PbergheiANKA_Genome 1126968 0.01 
PlasmoDB-44_PknowlesiH_Genome 1464970 0.01 
PlasmoDB-44_PfalciparumIT_Genome 1391017 0.01 
PlasmoDB-44_PfalciparumGA01_Genome 1388948 0.01 
PlasmoDB-44_PfalciparumDd2_Genome 1361026 0.01 
PlasmoDB-44_PovalecurtisiGH01_Genome 2013168 0.01 
PlasmoDB-44_Pgallinaceum8A_Genome 1503140 0.01 
PlasmoDB-44_PcynomolgiB_Genome 1580960 0.01 
Pbrasilianum 1884594 0.05 
PlasmoDB-44_PreichenowiCDC_Genome 1446111 0.05 
PlasmoDB-44_Pfalciparum7G8_Genome 1370010 0.05 
PlasmoDB-44_PfalciparumGN01_Genome 1422907 0.05 
PlasmoDB-44_Pfalciparum3D7_Genome 1400069 0.05 
PlasmoDB-44_PvivaxP01_Genome 1744686 0.05 
PlasmoDB-44_PmalariaeUG01_Genome 2017480 0.05 
Pbrasilianum_draft 1810942 0.05 
PlasmoDB-44_PfalciparumHB3_Genome 1368882 0.05 
PlasmoDB-44_Pchabaudichabaudi_Genome 1138527 0.05 
PlasmoDB-44_PfalciparumCD01_Genome 1412870 0.05 
PlasmoDB-44_PfalciparumGB4_Genome 1409521 0.05 
PlasmoDB-44_PbergheiANKA_Genome 1126968 0.05 
PlasmoDB-44_PknowlesiH_Genome 1464970 0.05 
PlasmoDB-44_PfalciparumIT_Genome 1391017 0.05 
PlasmoDB-44_PfalciparumGA01_Genome 1388948 0.05 
PlasmoDB-44_PfalciparumDd2_Genome 1361026 0.05 
PlasmoDB-44_PovalecurtisiGH01_Genome 2013168 0.05 
PlasmoDB-44_Pgallinaceum8A_Genome 1503140 0.05 




Since the completion of the Plasmodium falciparum 3D7 genome, there have been 
complete genomes generated for 11 other Plasmodium spp. Recently, a large-scale 
sequencing study used PacBio sequencing to assemble 11 strains of P. falciparum80. For 
all these genomes, extensive evolutionary analysis has been performed to determine the 
phylogeny for the Plasmodium spp. as shown in Figure 3.2a. This provides us with a 
ground truth state to evaluate the different clustering algorithms. 
The neighbor joining tree generated from the distance matrix produced by the three 
methods from genome FASTA files is shown below in Figure 3.2b, 3.2c, and 3.2d. Gen- 
too, Figure 3.2b, appears to recreate the expected phylogeny from the genome FASTA 
files, with the exception of the branch point corresponding to P. ovale curtisi. In 
comparison, both trees generated using the distance estimations from ANIm and Mash 
show erroneous branch points with respect to the expected tree. ANIm places P. malaria 
and P. brasilianum in a separate clade as compared to the rest of the species and indicates 
that P. knowlesi and P. vivax are closer to P. falciparum than to P. cynomolgi, contrary to 
what we observe from the Plasmodium spp. evolutionary tree. 
Mash on the other hand, correctly places P. vivax, P. cynomolgi, and P. knowlesi as 
closely related. However, P. berghei and P. chabaudi chabaudi are grouped with the same 
clade as P. falciparum and P. reichnowi, rather than P. ovale curtisi, as expected from the 
Plasmodium spp. evolutionary tree. 
One possible reason for the difference between the expected phylogenetic tree and 
the trees generated from Mash and ANIm could be the low complexity of the Plasmodium 
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genomes. The genomes from Plasmodium spp. are highly AT rich and contain many low 
complexity repeat regions within the genome. Since there are highly similar repeat regions 
present across the genomes, pairwise alignments can identify many regions of sequence 
similarity, but the average nucleotide identity of all the fragments can be low. When it 
comes to Mash, due to the probabilistic nature of MinHash, the sketch generated for each 
sample might have a skewed representation of fragments from the genomes due to the 
increased likelihood encountering a low complexity region in the genome. Since Gentoo 
uses k-mer counts, overlap of low complexity, high-count k-mers between the weighted 
Jaccard score, accounts for the abundance of the k-mer, thus normalizing its effect on the 
estimated distance. 
The effect of coverage and error rates on estimation of pairwise distance, was 
evaluated by running Gentoo and Mash on Illumina MiSeq paired-end data, simulated 
using DWGSIM90. Figures 3.2e and 3.2f show the neighbor joining tree generated from the 
genomic clustering of the simulated FASTQ datasets from Gentoo and Mash. Here again 
we observe that Gentoo is able to correctly reproduce the expected phylogeny, with the 
exception of the branch point corresponding to P. ovale curtisi. Since Gentoo utilizes the 
counts, as well, for the estimation of distances, the resolution of the estimated distances is 
lower than Mash, but the branch points are mainly as expected for the evolutionary 
analysis. Mash, however, places P. berghei and P. chabaudi chabaudi in a separate clade 
as compared to the other species and places P. ovale curtisi closer to P. brasilianum than 




        




                                                
3.2c) Mash on 20 Plasmodium species FASTA files.                                      3.2d) ANI on 20 Plasmodium species FASTA files.                 
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3.2 e) Gentoo on in-silico simulated reads from Plasmodium                3.2 f) Mash on in-silico simulated reads from Plasmodium 




                        
                       3.2 g) Finch on 20 Plasmodium species FASTA files. 
 
Figure 3.2: Comparison of neighbor-joining trees generated from pairwise distance 
estimation made using Gentoo (3.2b, e), Mash (3.2c, f), ANI (3.2d), and Finch (3.2g). Accuracy 
of the branch points was determined using the Plasmodium evolutionary tree (3.2a) published by 
Rutledge et al.,81. Branching point comparison shows that the neighbor-joining tree generated by 
Gentoo is the closest to the Plasmodium evolutionary tree, with the exception being the branch 
point for P. ovale curtisi. This hold true even when estimating distances from in-silico simulated 








The computational resources (i.e., memory, processing time) required for genome 
clustering were mapped using a memory profiling toolkit 
(https://pypi.org/project/memory-profiler). The memory usage was plotted as a function of 
time, as seen in Figure 3.3. As expected, Mash is the fastest and most memory efficient 
technique when it comes to clustering FASTA and raw FASTQ data. Though the 
calculation of ANI from assembled genomes has a low memory footprint, the process of 
generating assemblies from raw FASTQ data for a large number of samples is a memory 
intensive process. 
Although Gentoo is the slowest among the k-mer based methods in this comparison, 
it has a very low memory footprint. Considering the low memory footprint, the speed of 
Figure 3.3: Memory utilization by ANIm, Mash, Finch and Gentoo as a functional of time. 
Memory used by each tool for the clustering of 20 Plasmodium genomes was recorded. ANI, Mash 
and Gentoo were run using 30 concurrent processes. Finch does not allow for the user to specify 
number of concurrent processes. 
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the analysis can be optimized by adjusting the number of concurrent processes used for the 
pairwise comparison, in this study we used 30 concurrent processes. Finch on the other 
hand was the most resource intensive method, as expected, since it loads all the k-mers 
from each sample into memory for the pairwise comparisons. While this is possible while 
working with smaller FASTA files, the method is not scalable to larger FASTQ datasets. 
For these comparisons, all tools were run with 30 threads and 90 GB of RAM92. 
3.5 Clustering outbreaks of Candida auris infections in Colombia 
3.5.1 Materials and methods 
To evaluate the ability of Gentoo to cluster real-world outbreak isolates, we used whole 
genome sequencing data from Candida auris outbreaks in Colombia between 2015-201674. 
In the study, the authors isolated and sequenced C. auris from blood of infected patients. 
The samples were collected from three hospitals in Bogota, Cartagena and Barranquilla. 
The samples were sequenced using the Illumina HiSeq 2500. Illumina reads were 
aligned to a draft reference previously assembled using PacBio data, and variant calling 
was performed on the samples. The SNPs were used to construct a maximum parsimony 
tree. Here, we use these 33 samples to evaluate the ability of Gentoo to recapitulate the 
epidemiological data from74. FASTQ files were indexed using KAnalyze93 with a k-mer 






We downloaded 33 C. auris isolate that were sequenced from blood samples of patients at 
three hospitals in Bogota, Cartagena, and Barranquilla during a suspected Candida auris 
outbreak74. The raw data for these samples was downloaded from the NCBI Bioproject 
PRJNA470683. 
 K-mer counting on the raw FASTQ files was done using KAnalyze88. All k-mers 
of length 31 with count less than 5 and lowest base quality of less than 20 were discarded. 
Gentoo was run using the resulting KC (k-mer count) files as input. Pairwise comparisons 
between all 33 samples were performed using the algorithm described in Algorithm 1. A 
distance matrix was created from the weighted Jaccard scores, and a neighbor-joining 
phylogenetic tree was constructed for the outbreak isolates (Figure 3.3a). The results from 
Gentoo were compared with the published phylogenetic tree from74 (Figure 3.3a). In Figure 
3.3a we see that isolates from hospital A cluster together; however, isolates from hospitals 
B and D form two distinct clades. 
 The phylogenetic tree generated using Gentoo (Figure 3.3b), however, groups 
almost all the samples specific to their corresponding geographic origin, with the exception 
of samples B1156D (hospital D) and B11846A (hospital A). Though Gentoo is able to 
group isolates from each hospital correctly, the placement of samples from hospital A with 
samples from hospital D is at odds with the fact that hospital A is in northern Colombia 
and hospital D is in central Colombia. This discrepancy could be due to the noise arising 
from using k-mer profiles of the raw FASTQ files. Optimizing for k-mer size and minimum 
base quality of k-mers used for the analysis might resolve this discrepancy. The major 
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advantage of using an alignment free method, such as Gentoo, over a SNP-based distance 
estimation technique, is the significant gain in speed. Moreover, an alignment free 
approach allows for clustering sequences without the need of a reference genome. 
 
3.6 Discussion 
Estimated distances calculated between any two genomes may be skewed by depth of 
coverage when using raw NGS data versus assembled genomes. Here we demonstrate that 
using k-mer counts while clustering NGS datasets can overcome the effects of depth and 
sequence complexity in the calculation of pairwise distances. We demonstrated this by 
comparing Gentoo with other state-of-the-art methods for genomic clustering, such as ANI, 
Mash, and Finch to recreate the evolutionary tree for Plasmodium spp.  
Considering the AT-rich nature of the genome and high frequency of repeat 
sequences, percent identity-based methods, such as ANI, and k-mer occupancy-based 
methods, such as Finch and Mash, can produce results inconsistent with the expected 
phylogeny. The use of count information in the calculation of pairwise distance, as 
implemented by Gentoo, genomic difference and repeat composition between species to 
provide a better estimation of the phylogeny. We further showed that the count-based 
distance allows for accurate clustering from raw FASTQ data, without any prior error 
correction or assembly. This can prove extremely useful since genome assembly of large 
genomes is still a time and resource intensive process. 
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Figure 3.4: Tree generated from C. auris outbreak isolates from Colombian and Venezuelan isolates (BioProject ID: PRJNA470683).  Clades are 
shaded based on the geographical locations from which the samples within the clade were isolated. Samples shaded in red were isolated from Hospital A 
in Cartagena, those shaded in blue were isolated from Hospital B in Barranquilla, and those in purple were isolated from Hospital D in Bogota. a) Maximum 




 The applicability of using Gentoo in a real-world outbreak setting was evaluated by 
clustering C. auris isolates from an outbreak in northern and central Colombia. While Gen- 
too was able to cluster isolates from the same hospital more accurately in comparison to 
SNP based phylogeny, both SNP based phylogeny and Gentoo failed to cluster the samples 
by their geographic distribution.  
While this can be a comment towards the accuracy of the method, real world 
samples have a level of noise associated with each sample in terms of parasitemia (i.e., the 
admixture within the sample), and clustering algorithms may not be able to provide clear 
resolution at a geographic scale. Sequencing data from isolates cultured prior to sequencing 
can provide greater resolution as we see with C. auris isolates; however, complete 
geographic resolution is very difficult to achieve.  
Resolving the admixture in samples before clustering might achieve a better 
resolution. While there have been methods proposed for de-convolution of infection 
isolates from NGS data94,95, there is a long way to go before NGS data can be used to 
achieve perfect resolution of genomic clustering from blood isolates in outbreak scenarios. 
Additionally, when considering isolates from cases involving inadvertent contamination of 
biologics or in the case of bioterrorism, isolates are much more likely to show a greater 
level of clustering due to the clonal nature of the population, demonstrating the potential 




CHAPTER 4. NEXT GENERATION SEQUENCING AND BIOINFORMATICS 
PROTOCOL FOR MALARIA DRUG RESISTANCE MARKER SURVEILLANCE 
4.1 Abstract 
Recent advancements in Next Generation Sequencing (NGS) and bioinformatics along 
with decreasing costs per base sequenced have led to wider adoption of these methods in 
public health settings. While there is an abundance of protocols for NGS and 
bioinformatics analysis, many are tailored for research purposes and model organisms with 
extensive population-level data. These protocols are now being evaluated, modified, and 
standardized for routine use in public health laboratories. The vast majority of public health 
laboratories utilize the Illumina short-read sequencing technology and various different 
algorithms or variant callers for Single Nucleotide Polymorphisms (SNPs) based data 
analysis. In an effort to standardize SNP based analysis and overcome the inherent biases 
of any individual SNP based variant caller, a Next-generation Sequence analysis Toolkit 
(NeST) was developed. NeST provides a modular consensus-based variant calling 
framework for the identification of SNPs and short Insertions and Deletions (InDels). NeST 
uses a combination of variant callers that provide metrics to assess the accuracy of a variant 
found in a sample. NeST consists of four distinct modules: (1) PrepInputs, (2) 
VarCallEngine, (3) VCFToolkit, (4) Summarize. The utility and scalability of NeST is 
demonstrated by its recent adoption at the CDC for the molecular surveillance of malaria 
parasites48. In addition, using in silico data sets and Mycobacterium tuberculosis whole 
genome sequencing (WGS) data, we assess NeST’s accuracy, sensitivity, and specificity 




The spread of antimalarial drug resistance is a major threat to controlling and eradicating 
malaria. As described in Chapter 1, antimalarial drug resistance can be linked to mutations 
in crucial genetic markers in Plasmodium falciparum. Molecular surveillance of drug 
resistance relies on tracking the prevalence of these mutations in a given population. 
 Next Generation Sequencing (NGS) has had an enormous impact on molecular 
surveillance of drug resistance. With the improvement in second-generation NGS 
technologies, including throughput and reduced cost of sequencing, routine NGS based 
molecular surveillance of drug resistance in malaria is becoming more widely adopted. 
Second-generation Illumina short-read NGS is now one of the most widely used 
sequencing techniques in both research and public health sector. Short-read sequencers 
generate a large amount of high-quality sequencing data and can provide a cost-effective 
method for the surveillance of drug resistance for hundreds of samples by taking advantage 
of the ability to multiplex samples in a single run. The major bottleneck, however, is the 
availability of standardized, consensus-based bioinformatics tools to analyze this data. 
 Genotypic determination of drug resistance mainly relies on the identification of 
Single Nucleotide Polymorphisms (SNPs) and short Insertions and Deletions (InDels) in 
genes identified as key markers for drug resistance15,84,85. Accuracy of the predicted 
genotypic markers for resistance is contingent on the accuracy of the variant calls made 
from NGS data. 
 A large number of tools and pipelines have been developed for variant calling from 
NGS data60,64,65,96–98. Studies have shown that there is a considerable amount of 
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discrepancy in the variant calls made from different algorithms63, leading to is an 
increasing reliance on variant filtration algorithms to select high-quality variants. Variant 
filtration algorithms utilize true variant calls from the population and apply machine 
learning to identify high-quality calls from the sample data98. For most organisms, 
however, population-level information is not available. 
 Hard filters on variant calls have been suggested to circumvent the lack of 
population-level information, but they are hard to standardize across sequencing 
protocols84. Having a consensus variant call that relies on different algorithms can provide 
an alternate discrete metric to determine the quality of the calls made. 
 In this chapter, we introduced a novel Next Generation Sequencing analysis toolkit 
(NeST) for the identification of high-quality consensus calls from NGS datasets. First, we 
will describe in detail four key modules that make up the framework and detail the 
standardization of inputs and results generated by NeST. 
 Next, we will demonstrate the advantages of using a consensus framework over 
individual pipelines by studying the variability of the results produced by different variant 
calling methods using in-silico datasets. Third, we will describe the utility of the framework 
by highlight the implementation of NeST as a framework for the surveillance of 
antimalarial drug resistance at the Centers for Disease Control and Prevention (CDC). 
Finally, will show the scalability and adaptability of the framework to other outbreak 





4.3 NeST variant calling framework 
Next-generation Sequence analysis Toolkit (NeST) (https://github.com/shashidhar22/ 
NeST), is a modular consensus-based SNP calling framework for variant calling that 
integrates open-source bioinformatics tools for quality correction, alignment, and SNP 
calling using NGS data. The key design consideration made during the development are i) 
Reproducibility, ii) Cross platform compatibility, iii) Usability, iv) Modularity, and v) 
Scalability. These principles are implemented through four key modules in NeST.  
4.3.1 PrepInputs Module 
To improve reproducibility and usability, for each study NeST generates a study object 
containing all the information regarding the samples, the reference genome, gene 
boundaries, and variants of interest for the study provided by the user. The sample data can 
be provided to NeST in three formats: a path to the folder containing the raw FASTQ files, 
an SRA accession list or a tab-delimited list with sample names and associated FASTQ 
files or SRA accession number. The module downloads the FASTQ files using 
SRAToolkit99, merges technical replicates and collects all the files required for the 
processing of samples in a study. The module parses each FASTQ file associated with a 
sample and uses the FASTQ headers to retrieve the relevant sequencing run information, 
including sample name, library type, and sequence length. FASTQ-files are grouped by 





4.3.2 VarCallEngine Module 
Three sets of SNP calls are generated for each sample by the VarCallEngine module. 
Sequencing reads are first trimmed and cleaned based on pre-defined quality thresholds, 
and adapters removed using BBDuk100. Cleaned reads are then aligned to a reference 
genome using one of the four included aligners (BWA53, Bowtie252, BBMap100, SNAP101). 
If none are specified, BWA is run using default settings. The alignments are then sorted, 
de-duplicated, and read group information added using SAMTools58 and Picard 
(https://broadinstitute.github.io/picard). The de-duplicated BAM files are then used for 
SNP (Single Nucleotide Polymorphism) calling using Freebayes60, GATK61 and 
SAMtools-BCFtools58. Due to variation in the representation of InDel by different tools, 
as of the current version, NeST performs a consensus variant calling only on SNPs. InDels 





Figure 4.1: NeST flowchart detailing the four main modules. PrepInputs consolidates all 
user inputs. VarCallEngine executes three variant calling pipelines. VCFToolkit annotates the 
variant calls and merges VCF files to provide a consensus variant call. Summarizer generates 
human readable reports and figures from the NGS analysis. 
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4.3.3 VCFToolkit Module 
The VCFToolkit Module is a custom Variant Call Format (VCF) file parser used to filter, 
merge, and annotate variant calls from the different variant calling algorithms implemented 
in NeST. The parser is composed of sub-modules, allowing for further customization. 
 The filter module allows the user to filter SNPs by standard VCF fields. The VCF 
files are then annotated using a BED file, with designated gene boundaries, provided by 
the user. BED files are easy to modify and allow for easy annotation of VCF files for 
organisms that lack an annotated gene or genome database. 
 The variant calls are then combined using the merge module. This module 
sequentially parses through the VCF files and merges all headers, INFO, and FORMAT 
field values in the VCF file. The INFO field called Confidence is added, which indicates 
the number of variant callers that identified a SNP. An additional Sources field is added to 
indicate the callers that identified each variant. A list of VCF files are provided to the merge 
module and are split into pairs and recursively merged. Thus, allowing for easy merging of 
results from multiple variant callers. 
4.3.4 Summarize Module 
The summarize module combines and compares the annotated SNPs for each sample from 
the VCF files. A data-frame is created showing the presence of known SNPs (i.e., user-
defined via the reportable SNPs document) across all samples. Non-user defined novel 
exonic and intronic SNPs are grouped into two separate tables (Table 4.4). Custom R 
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scripts then automatically generate figures summarizing the sequencing depth (Figure 4.3) 
and allele frequency (Figure 4.4). 
4.3.5 Accessibility and cross platform compatibility 
As we have seen in the previous section, NeST stitches together various open-source tools, 
threading the results from one tool to the next, and automating the whole process. The 
increased number of dependencies creates multiple failure points within the framework. It 
is essential to keep this in mind while designing any bioinformatics framework, that most 
of the tools used are open source in nature. The dependencies usually also vary in the 
language used to develop the tool, the dependencies used by the tools, as well as the 
frequency with which the tools are updated or maintained. Table 4.1 lists the various design 
considerations that went into the evolution of the NeST variant calling framework. In this 
section, we will focus on virtual environments and cross-platform compatibility of the 
framework. 
NeST relies on the Anaconda virtual environment to ensure version control of the 
tools used within. The Anaconda installation provides a framework to maintain exact 
versions of dependencies required for any analysis. Installation of most tools requires either 
admin or superuser privileges depending on the platform being used. Virtual environments, 
as the name suggests, create a virtual space within the users' profile. Here the user can 
install, modify, and delete any package without affecting the system environment that is 
shared by all the users. This allows the user to maintain many different versions of 










Feature NeST v2 NeST 
v1/MaRS 
CoVaCS Omics Pipe NARWHAL 
Consensus variant calling ✓ ✓ ✓ 
  
Open source ✓ ✓ 
 
✓ ✓ 
Multi-sample analysis ✓ ✓ ✓ ✓ ✓ 
Automated FASTQ retrieval from SRA ✓ ✓ ✓ 
  
Amplicon Sequencing Data ✓ ✓ 
 
✓ ✓ 
Automated figure generation ✓ ✓ 
   
Summarization reports ✓ ✓ 
   





Local installation ✓ ✓ 
 
✓ ✓ 
Cloud deployable ✓ ✓ ✓ 
  





Pathogen agnostic ✓ 
  
✓ ✓ 
Modular variant annotation toolkit ✓ 
    








Virtual environment with version-controlled 
dependencies 
✓ 







Figure 2.2: NeST virtual environment. 
70 
 
The virtual environment is usually controlled using a YAML file. Figure 4.2 shows 
the YAML file used to generate the NeST virtual environment. The channels mentioned in 
the YAML file maintain the version of the dependencies listed. Miniconda downloads the 
required version of each of the dependencies and installs them to the local virtual 
environment. The bioinformatics tools used in NeST are maintained by BioConda102. The 
advantage of using a virtual environment is the cross-platform compatibility that is offered. 
Miniconda can be deployed on Linux and OSX frameworks, as well as The Linux 
subsystem for Windows. Thus, allowing users on all platform access to the framework. 
4.3.6 Input and Result standardization 
In this section, we will describe the various inputs that NeST requires for any analysis as 
well as describe the outputs generated from the analysis. NeST is designed to reduce the 
amount of user intervention with regards to inputs that the user needs to provide. However, 
to enable standardization of inputs across all organisms, we require that a particular file 
format be followed for the three inputs listed below: 
1. FASTQ files: 
The PrepInputs module in NeST highly simplifies the management of FASTQ files. The 
module accepts two input formats. 
a. Input directory path: 
The user provides the path to a folder containing FASTQ files. The files with the path are 
recognized by the file extension. The allowed extensions include fq, fq.gz, fastq or fastq.gz. 
The naming convention followed for paired sequencing read files must be _1, _r1 or _R1. 
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b. SRA accession list: 
The user also has the option to provide a text file with a list of SRA experiments, with one 
SRA number per line of the file. This can be exported from the SRA run selector tool. An 
example SRA accession file is provided with the NeST installation. 
2. BED format: 
The BED (Browser Extensible Data) is an easy and lightweight format to list annotations 
for a genome. NeST uses a full BED or BED 12 column format file as a guide to annotate 
variants with codon and amino acid changes. The separation of contig, gene and exon level 
information make this format highly portable across genomes. The BED 12 column format 
for most organisms can be export from the UCSC table browser. 
3. Variants of Interest: 
The Summarize module in NeST allows for collates all the variants (SNPs and InDels) 
called from all the samples in the study. If a user specifies a list of variants of interest, a 
separate table will be created for these variants. The variants can be in comma separated, 




Table 4.2: Variants of interest table. Each row should contain the Chromosome, Gene name, 
reference amino acid, alternate amino acid and the amino acid location for the variant of interest. 
Chrom Gene RefAA AAPos AltAA 
PfCRT PfCRT C 72 S 
PfCRT PfCRT V 73 V 
PfMDR1 PfMDR1 N 86 Y 
PfMDR1 PfMDR1 Y 184 F 
MT CYTOb I 258 M 
 
Each NeST analysis produces a standard list of tables and figures that summarize the data 
from the variant calling experiment. Below we describe the different output that are 
generated by NeST. 
1. Report files: 
NeST generates tables that summarize the different types of variants found in the samples. 
All the tables will be stored under the Reports folder inside the output directory. Table 4.3 
describes the different files that are generated by NeST.  
Table 4.3: List of summary files generated by NeST. 
File  Description 
Study known variants This file contains the calls for each of the variants of interest, for each of the 
samples. The table also lists the variant call metrics for the variants 
Study known variants allele 
frequency 
This file lists the allele frequency for each of the variants of interest, for each 
of the samples in the study 
Study known variants depth This file lists the depth for each of the variants of interest, for each of the 
samples in the study 
Study novel exonic variants  This file lists all the novel exonic variants found in all the samples in the 
study along with the variant call metrics 
Study novel intronic variants This file lists all intronic variants found in all the samples in the study along 
with the variant call metrics 
Study novel variants allele 
frequency 
This file lists the allele frequency for each of the novel variants, for each of 
the samples in the study 
Study novel variants depth This file lists the depth for each of the novel variants, for each of the samples 




a. Study Depth: 
Read depth of coverage for SNPs associated with drug resistance. SNP loci are shown on 
the on the x- axis, and the read depth of coverage on the y-axis. The colors indicate the 
genes that were amplified during sequencing (Figure 4.3). 
b. Reportable SNPs: 
Bar graph depicting the wild type, major and minor allele frequencies of associated and/or 
confirmed resistance SNPs. Allele frequencies are indicated on the x-axis, and the variants 
of interest are listed along the y-axis (left). The number of samples that had a particular 
mutation is indicated on the y-axis (right). The color coding indicates the type of mutation 
found in the samples; blue is for wild type, green for minor allele mutation and red for 
major allele mutation (Figure 4.4). 
c. Novel Intronic SNPs: 
The figure follows the same format as Figure 4.4. The mutations indicated on the y-axis 
are any mutation that did not lie within the gene boundaries defined in the BED file, i.e., 
intronic and intergenic mutations. 
d. Novel Synonymous Exonic SNPs: 
Novel synonymous exonic SNPs are also reported in the same format as Figure 4.4. The 
mutations indicated on the y-axis are synonymous SNPs that lie within the exons of the 




e. Novel Non-Synonymous Exonic SNPs: 
Following a similar format to Figure 4.4, the graph catalogs the non-synonymous mutations 
found in the exonic regions of the genes of interest, which were not previously listed as 
variants of interest by the user.  
The modularity of the NeST framework and standardization of results generated 
from the framework allow users not only to identify high-quality variants but also allow 
for the benchmarking of commonly used algorithms for variant calling. In the next section, 
the accuracy of standard variant calling algorithms using in-silico datasets from 
Plasmodium genes is evaluated. 
4.4 In-silico evaluation of variant calling accuracy from NGS datasets 
4.4.1 Materials and methods: 
To evaluate the accuracy of each methodology implemented in NeST and added value of 
consensus variant calling, 108 in-silico MiSeq dataset with varying coverage and sequence 
error rates were compared. Complete gene sequences for PfCRT, PfMDR1, PfK13, 
PfDHPS, PfDHFR, and the complete mitochondrial genome from Plasmodium falciparum 
3D7 genome were used as the reference. The mutation rate for the in-silico samples was 
set to 0.001%, with 10% of the in-silico mutations generated as InDels using DWGSIM90 
as described in Table 4.1. The specificity and sensitivity of each variant caller was assessed 
using the variant call files generated by DWGSIM as a truth set.  
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Figure 4.3: Depth of sequencing coverage across regions of interest. The y-axis indicates the sequencing read depth; the x-axis lists the variants of interest as 




Figure 4.4: Allele frequency distribution across variant of interest. The y-axis lists variants of interest 
as specified by the user. The x-axis indicates the allele frequency in the sample set. The color of the 
indicate the allele balance for the variant. Blue indicates wild type, green indicates variant in the minor 
allele, and red indicates presence of major allele variant. 
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Set# Coverage Read count Error rate MAF 
1 100 4010 0.001 0.5 
2 500 20051 0.001 0.5 
3 1000 40102 0.001 0.5 
4 100 4010 0.001 0.25 
5 500 20051 0.001 0.25 
6 1000 40102 0.001 0.25 
7 100 4010 0.001 0.1 
8 500 20051 0.001 0.1 
9 1000 40102 0.001 0.1 
10 100 4010 0.001 0.05 
11 500 20051 0.001 0.05 
12 1000 40102 0.001 0.05 
13 100 4010 0.005 0.5 
14 500 20051 0.005 0.5 
15 1000 40102 0.005 0.5 
16 100 4010 0.005 0.25 
17 500 20051 0.005 0.25 
18 1000 40102 0.005 0.25 
19 100 4010 0.005 0.1 
20 500 20051 0.005 0.1 
21 1000 40102 0.005 0.1 
22 100 4010 0.005 0.05 
23 500 20051 0.005 0.05 
24 1000 40102 0.005 0.05 
25 100 4010 0.01 0.5 
26 500 20051 0.01 0.5 
27 1000 40102 0.01 0.5 
28 100 4010 0.01 0.25 
29 500 20051 0.01 0.25 
30 1000 40102 0.01 0.25 
31 100 4010 0.01 0.1 
32 500 20051 0.01 0.1 
33 1000 40102 0.01 0.1 
34 100 4010 0.01 0.05 
35 500 20051 0.01 0.05 




The accuracy of the different variant calling algorithms was evaluated using, 108 paired-
ended in-silico datasets were following the coverage, error rate, and minor allele frequency 
combination listed in Table 4.4. The maximum error rate for samples generated was limited 
to 1% since any error rate higher than 1% resulted in all reads being discarded during the 
QC step, thus not resembling any real-world situation which would be encountered. For 
each of the samples the mutation rate was set to 0.001% and rate of InDels was set to 10% 
of all mutations simulated. 
Table 4.5: Precision and recall values for SNPs and InDel calls made by standard variant 
callers against in-silico datasets from Plasmodium falciparum genes.  
Variant caller All variant calls (2241) SNPs (2043) InDels (198) 
 Precision Recall Support Precision Recall Support Precision Recall Support 
NeST 61.88 87.50 3169 63.36 94.66 3052 23.07 13.63 117 
NeST (Conf=2) 99.88 77.10 1730 99.94 84.53 1728 50 0.50 2 
HaplotypeCaller 98.04 78.40 1792 99.94 84.67 1731 44.26 13.63 61 
Samtools 97.83 70.72 1620 99.81 77.53 1587 3.03 0.55 33 
Freebayes 62.72 85.58 3058 63.23 93.88 3033 0 0 25 
The variant calls made with NeST, Freebayes, Samtools, GATK HaplotypeCaller 
and NeST calls which were made by at least two of three variant callers present in the 
framework were compared with the mutation list generated for each sample by 
DWGSIM90. Precision and Recall was calculated by measuring the number of instances 
where the calls made through the different protocols exact matched in-silico mutations 
generated.  
 Table 4.5 shows the precision and recall of the different protocols broken down by 
the type of variant call. From the table, we can see that relying on the simple comparison 
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of InDel calls to arrive at a consensus variant call is not a viable option. Primarily due to 
the differences in the representation of InDels by different variant calling algorithms. 
Precision values for InDel calling are greatly improved if InDels are unfurled by base 
location and then compared, as suggested by Krusche et al.103. The current version of NeST 
is primarily aimed at identifying SNPs conferring antimalarial drug resistance. InDels are 
just reported as is, giving the user the option to consider InDels for their downstream 
analysis. 
 
Figure 4.5: Distribution of false positive and false negative calls made by the different variant 
calling methods as a function of sequencing depth and error rates. The swarm plot shows the 
density of false positive and false negative calls for each condition. 
With SNP calling, however, HaplotypeCaller and Samtools show high precision 
and recall. Freebayes, on the other hand, shows significantly lower precision but high recall 
when compared to the other two callers, as well as NeST (Confidence =2). To investigate 
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this further, the variance in error in the variant calls w.r.t coverage, sequence error rate, 
and MAF were assessed. From Figure 4.5, the precision of Freebayes is affected to a more 
significant extent by sequence error rate than the other methods implemented. It is 
interesting to see that with an increase in coverage, the number of false-positive calls made 
by Freebayes significantly decreases. Samtools and GATK seem to take a more 
conservative approach while calling variants, thus showing greater precision, and 
consistent recall across the different scenarios described here. 
 From the data it’s clear that NeST results filtered on at least two variant callers 
detecting the variant, shows higher precision than using any of the methods on their own. 
When it comes to consensus InDel calling, the biggest bottleneck is the differing 
representations of InDels by the different methods implemented. Though decomposing the 
InDel into its constituent bases can enable consensus InDel calling, the current 
implementation of NeST reports InDels in the native forms as called by the different variant 
caller.  
4.5 Identifying variants conferring antimalarial drug resistance in Plasmodium 
falciparum from Targeted Amplicon Deep Sequencing datasets 
4.5.1 Materials and methods 
Amplicon sequencing is a targeted sequencing approach where PCR products or amplicons 
from a specific region in the genome are sequenced to a very high depth of coverage. This 
enables the accurate characterization of the genomic variants. Multiplexing of these 
amplicons allows for a large number of samples to be sequenced in a single sequencing 
run. Using the targeted amplicon deep sequencing protocol developed for eight genetic 
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markers for drug resistance in Plasmodium falciparum48, NeST was used to identify 
variants associated with drug resistance from these samples. 
 A total of 1,081 Plasmodium falciparum samples from more than 28 different 
regions (NCBI BioProject PRJNA428490) have been sequenced till date. From this larger 
dataset, 243 isolates were sequenced using Sanger sequencing (Figure 4.1). Using these 
243 samples the accuracy of the variant calls from NeST were evaluated by comparing the 
Sanger and NGS variant calls. 
 The accuracy of NeST was determined by its ability to identify 29 SNPs associated 
with drug resistance that were amplified in the Sanger sequencing runs. The results from 
NeST were compared with variant calls from Geneious98, a commercial off the shelf 
(COTS) bioinformatics toolkit for Sanger and NGS data analysis. 
 Leveraging the HPC compatibility of NeST, the framework was made available to 
all the groups at the CDC through their internal HPC framework. In collaboration with the 
Office of Advanced Molecular Detection (OAMD) at the CDC, a cloud-based web version 
of NeST was deployed on the CDC OAMD portal, accessible by all collaborating public 




Figure 4.6: Summary of the geographical location of all 243 P. falciparum samples. Legend 
indicates the number of samples from each region. 
  
4.5.2 Results 
The Malaria Resistance Surveillance (MaRS) amplicon sequencing protocol developed by 
the Malaria Branch at the CDC currently uses PCR primers to amplify out whole gene 
sequences for these eight markers (PfCRT, PfMDR1, PfDHPS, PfDHFR, PfK13, PfCOXIII, 
PfCOL, and PfCYTb). These eight markers were amplified in the 243 samples of imported 
malaria cases into the United States, using the MaRS protocol. NeST was used to identify 
mutations conferring drug resistance. The results were validated using variant calls from 
Sanger sequencing data available for all 243 samples. 
 As indicated in Figure 4.7, NeST was able to detect 444 variants in the 243 samples, 
that were previously missed by Sanger sequencing and Geneious. Six hundred three 
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variants were only detected through NGS data. When compared to Geneious, NeST and 
Sanger were able to identify 129 SNPs that were missed by Geneious. Only 21 variants 
from all 243 samples were missed by NeST but detected either with Sanger (20 variants) 
or Geneious. 
 Figure 4.8 shows the overlap of variant calls made by the different tools used within 
NeST. From the figure we see that 1566 variant calls detected from the Sanger, 1543 were 
found by at least two variant callers implemented in NeST. Of 603 variants only identified 
from NGS data, 577 were identified by at least two variant callers in NeST. Freebayes 
detected the largest number of variant calls that could not be corroborated with the other 
methods. 
Samtools detected the greatest number of variant calls, which could only be 
corroborated with sanger data. All variant calls made by GATK, on the other hand, could 
be verified by at least one of the variant callers used in the comparison or sanger sequencing 
data. Thus, GATK again shows that while being conservative in the number of calls made, 
the accuracy of the calls made by the tools is the highest amongst the tools compared here. 
Apart from the variants of interest, any other variant called by NeST will be stored 
in separate outputs as novel intronic or novel exonic variants while novel exonic variants 
are only reported if at least two out of the three callers found the variant. Novel intronic 
calls are reported even when just one of the callers found the variant. This separation and 




Figure 4.7: The overlap of variant calls made by NeST, Geneious, and Sanger sequencing calls. The bar graph on the left 
shows the total number of variant calls made by the different methods. The graph on the right shows the extent of overlap of variant 




Figure 4.8:  The overlap of variant calls made by NeST, Geneious, and Sanger sequencing calls. The bar graph on the left shows the total 
number of variant calls made by the different methods. The graph on the right shows the extent of overlap of variant calls made by Samtools, GATK 




Figure 4.9 shows novel non-synonymous exonic mutations in the PfK13 gene. From 
the figure, we can see that 115 of the 243 samples analyzed had the PfK13: K189T 
mutation. While it is difficult to arrive at any conclusion about the significance of this 
mutation toward drug resistance with the current sample set. Capturing this information 
can help with future inquiries. 
 
Figure 4.9: Frequency of novel non-synonymous mutations in the exonic region PfK13 that 
were found by at least two variant callers. 
Our analysis of the 243 P. falciparum isolates shows the advantage of using a consensus-
based variant calling system like NeST for tracking resistance in malaria. To ensure that 
NeST can be deployed quickly across different platforms with varying resources available, 
NeST using the BioConda framework to setup necessary dependencies. It is also structured 
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such that the user requires a minimum of 4GB of RAM for analysis, which is commonplace 
in most modern-day computers. For situations where adequate resources to run NeST are 
not available, a web-based version of the framework was also made available to all 
collaborating public health labs at CDC, through the Office of Advanced Molecular 
Detection (OAMD) web-portal (Figure 4.10) as the MaRS pipeline. 
 
Figure 4.10: NeST/ MaRS app available on the OAMD Bioinformatics platform. 
 
4.6 Evaluating accuracy of variant calling derived genotypes at predicting 
phenotypic drug resistance in Mycobacterium tuberculosis 
4.6.1 Material and methods 
To test the utility of NeST for a bacterial pathogen, the performance of NeST at predicting 
drug resistance in Mycobacterium tuberculosis isolates from the CRyPTIC consortium 
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study83 was evaluated. From the CRyPTIC consortium study, 8351 samples along with 
their corresponding SRA accession numbers were collected. NeST was used to identify 
mutations conferring drug resistance to four drugs Rifampicin, Isoniazid, Ethambutol, and 
Pyrazinamide. We looked at mutations in 9 genes katG, embA, embB, embC, ahpC, pncA, 
inhA, fabG1 and rpoB. 
 The study presented 10210 Mycobacterium tuberculosis isolates with associated 
phenotypic resistance information for five anti-biotics lists of anti-biotics. They tested the 
accuracy of genotypic variant calling markers from NGS datasets at predicting phenotypic 
resistance by implementing a Standard variant calling a pipeline. However, of the 10210, 
only 8351 samples available from NCBI’s Sequence Read Archive (SRA) could be 
associated with the phenotypic associations. Only these 8351 samples were considered for 
further analysis. 
 Here we evaluate the accuracy of NeST at predicting phenotypic resistance to these 
drugs using resistance variant markers for these five drugs. The sensitivity and specificity 
of predicting phenotypic resistance using a single variant caller as performed in the 
CRyPTIC consortium study and a consensus variant calling approach implemented in 
NeST, was tested. Samples were analyzed using the NeST variant calling framework and 
classified as resistant or susceptible based on presence or absence of variants known to 
confer drug resistance to four first line treatments against M. tuberculosis infections.  
4.6.2 Results: 
To test the utility of NeST in different public health settings, we evaluated the performance 
of NeST at predicting drug resistance in Mycobacterium tuberculosis isolates from the 
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CRyPTIC consortium study83. From the CRyPTIC consortium study, we were able to 
gather samples and their corresponding SRA accession numbers for 8351 samples. We 
used to NeST to identify mutations conferring drug resistance to four drugs Rifampicin, 
Isoniazid, Ethambutol, and Pyrazinamide. In particular, we looked at mutations in 9 genes 
katG, embA, embB, embC, ahpC, pncA, inhA, fabG1 and rpoB. 
 The current implementation of NeST leverages the Python multiprocessing 
framework. This allows the distribution of the analysis across multiple threads to achieve 
the parallelization of the process. While multiprocessing is suitable for small studies, as we 
saw with the Plasmodium dataset, it is not efficient when working with a large number of 
samples. Leveraging the multi-node structure of an HPC environment can drastically speed 
up the analysis. To this end, we developed a recipe for NeST to utilize the multi-node 
architecture of the HPC system, PACE92, offered at the Georgia Institute of Technology. 
Since the MOAB scheduler used by PACE, is a commonly used scheduler for HPC 
clusters, the same recipe can be used across any cluster implementing a MOAB scheduler. 
Leveraging this architecture, we were able to analyze the 8351 WGS samples in 40 hours. 
The samples were classified as resistant to the drugs if an SNP known to confer drug 
resistance was found in the sample. 
 For comparison, the convention set by the published study of classifying a sample 
to be susceptible to drugs was followed; if it lacked any of the SNPs known to confer drug 
resistance. Precision and recall values were calculated for each of the labels (Resistant, 
Susceptible). Table 4.6 shows the conditions under which a true positive, false positive and 
false negative call would be made for both the resistant and susceptible label.  
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Table 4.6: Truth table for genotypic and phenotypic resistance or susceptibility. 
 Genotypic resistance Genotypic susceptibility 
Phenotypic resistance True positive resistance False negative resistance 
False positive susceptibility 
Phenotypic susceptibility False negative resistance 
False positive susceptibility 










𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 ∪ 𝐹𝑎𝑙𝑠𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒
 (4.2) 
As per the definition of precision and recall, Eq (4.1) (4.2), low precision for resistance 
would imply that more samples were predicted to be resistant from the NGS data, than 
what was observed from the clinical phenotype. A low value for recall would imply fewer 
samples were predicted to be resistant from the NGS data, than what was observed from 
clinical phenotype. By the same logic, a low precision value corresponding to susceptibility 
to a drug would imply that there were a greater number of samples that were labeled 
susceptible than observed through phenotypic data. Moreover, low values of recall would 






Table 4.7: Precision and recall values for the genotypic prediction of phenotypic resistance 
or susceptibility against anti-TB drugs. 
Drug Label NeST CRyPTIC consortium Support 
Precision Recall Precision Recall 
 
Rifampicin Resistant 0.94 0.96 0.96 0.95 2659 
Susceptible 0.98 0.97 0.98 0.98 5692 
Pyrazinamide Resistant 0.46 0.43 0.59 0.75 1016 
Susceptible 0.92 0.93 0.96 0.93 7335 
Ethambutol Resistant 0.66 0.83 0.66 0.86 1488 
Susceptible 0.96 0.91 0.97 0.91 6863 
Isoniazid Resistant 0.93 0.93 0.94 0.93 2884 
Susceptible 0.97 0.96 0.96 0.97 5467 
 Table 4.7 shows the precision and recall corresponding to resistant and susceptible 
calls from NEST and the CRyPTIC consortium pipeline. Based on the interpretations of 
precision and recall for the different scenarios, we can say that NeST classifies a lot more 
samples as resistant to the four drugs, than the Samtools pipeline used by the CRyPTIC 
consortium. However, it would be unwise to conclude that NeST is better at detecting 
phenotypic resistance than a single pipeline method or vice versa. While from the previous 
sections we see that the consensus framework can achieve higher accuracy of variant calls, 
there are many factors involved with phenotypic resistance than cannot be accounted for 
by a naive classification of resistance based on presence or absence of variants in the 
samples. 
 From the data provided in Table 4.7, however, the precision and recall associated 
with the phenotypic prediction of susceptibility to a drug was above 90% for both 
CRyPTIC consortium pipeline and NeST. It might be tempting to conclude here that, 
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absence of the mutation associated with resistance can imply phenotypic susceptibility. 
The absence of a variant call from NGS data is dependent on many factors. Such as the 
purity of DNA extracted, the precision of the library prep, the error rates associated with 
the sequencing technology used, and finally, the sensitivity of the NGS analysis framework 
used. More evidence is needed before any conclusion can be made on the accuracy of 
genotypic predictions of phenotypic resistant. Based on the analysis presented herein, 
NeST provides a scalable framework to analyze NGS data from large-scale studies. The 
consensus framework offered provides a metric to assess high confidence variant calls. 
These two features can significantly improve the utilization of NGS data towards molecular 
surveillance of drug resistance. 
 
4.7 Discussion 
Though variant calling from NGS data has been an established technique for some time 
now, there is ample evidence to show that variant calls made by different tools are not 
always consistent with each other63,65. From the analysis using in-silico datasets generated 
from genes associated with drug resistance in Plasmodium falciparum, its clear that 
variance in results will occur with different variant calling algorithms and that some of this 
variance can be overcome by using a consensus based variant calling method. 
 NeST is already being used for routine molecular surveillance of antimalarial drug 
resistance at the CDC. Based on the analysis presented earlier, NeST also performs better 
than commercial toolkits such as Geneious at identifying genetic markers for antimalarial 
drug resistance. The scalability of NeST is demonstrated by its availability through the 
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CDC HPC web portal. Furthermore, NeST is easily scalable for large datasets, as 
demonstrated by the analysis of the 8,351 NGS samples from the CRyPTIC 
Mycobacterium tuberculosis consortium study.  While most of the variant calls associated 
with drug resistance were able to predict phenotypic resistance to a drug, some drugs, such 
as Pyrazinamide and Ethambutol, the SNP calls were not good predictor of phenotypic 
resistance. The SNP calls predicted a lot more samples to be resistant to a drug than 
phenotypically observed. This may be due to the various factors that can affect variant 
calling from NGS data, such as coverage, error rate, and genomic complexity. Additionally, 
the mechanisms that govern resistance to a drug are complex and thus are not easily 
predicted by naive presence or absence test of variants associated with drug resistance – 
genotypic resistance is not phenotypic resistance and vice versa. 
 In summary, the consensus-based variant calling framework can overcome the 
biases of any individual bioinformatic algorithm and provides a metric to assess the quality 
of mutations detected from NGS datasets. Though by its nature, a consensus-based system 
will be more conservative in calling variations from the sample data, consensus-based 
methods can reduce the likelihood of erroneous calls, which is crucial for molecular 
surveillance in public health settings. NeST was able to identify more variants associated 
with drug resistance, than other commercial NGS analysis platforms. The scalability and 





CHAPTER 5. CONCLUDING REMARKS 
The work described in this thesis highlights the challenges faced in genetic epidemiology 
of malaria and proposes methods to address these challenges given the current technology. 
 In Chapter 2, we describe the existing methodologies for variant calling and 
genomic clustering from NGS data. The advantages and disadvantages of state-of-the-art 
genomic clustering and variant calling algorithms were discussed. The underlying principle 
for two new methodologies, NeST and Gentoo, introduced through this work to overcome 
the pitfalls of existing solutions in variant calling and genomic clustering when applied to 
NGS data in a public health setting.  
 In Chapter 3, I further expanded on the k-mer based alignment-free clustering 
algorithm, Gentoo. The improved accuracy of Gentoo over existing methods for genomic 
clustering of NGS data from Plasmodium spp., was demonstrated. I further showed that 
Gentoo was able to cluster better genomes from Candida auris outbreaks in Colombia, 
based on local similarities between isolates from a given outbreak, when compared to SNP 
based phylogeny techniques. 
 Memory profiling of Gentoo shows a significant reduction in the time of execution 
and resources required for pairwise distance estimation that can be achieved with Gentoo. 
Gentoo required 121 MB of RAM and took 10 minutes to cluster all 20 genomes from the 
Plasmodium study. While our previously developed method, Finch, required 10 GB of 
RAM and took 30 minutes to perform all 210 pairwise comparisons. The time of analysis 
went up to 60 minutes when Gentoo used FASTQ files directly, but the memory utilization 
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remained the same. While Mash was the most efficient algorithm, in terms of runtime and 
memory utilization, Gentoo was more accurate at reproducing the Plasmodium 
evolutionary tree. 
 Chapter 4 describes a modular, scalable, consensus-based framework, NeST, for 
the molecular surveillance of drug resistance using variant calling from NGS datasets. 
There has been enough evidence to show that variant calling methodologies are not 
consistent with each other, though methods do exist to filter low-quality variants. These 
variant filtration techniques are not applicable for smaller organisms such as Plasmodium 
falciparum or Mycobacterium. tuberculosis. 
 NeST generates a consensus call using multiple variant calling algorithms to 
overcome the potential bias associated with each method on its own. We evaluated the 
benefits of a consensus caller, using in-silico datasets generated from molecular markers 
associated with drug resistance in P. falciparum as well as the amplicon sequencing data 
from blood spots of samples infected with P. falciparum. We demonstrated the scalability 
of the framework by analyzing 8351 M. tuberculosis on an HPC cluster, with an average 
time of analysis of 4 hours for 100 WGS samples of M. tuberculosis. 
 We show that there is a consistency in the precision when calling variants using a 
consensus-based approach as compared to each method separately. However, there is drop 
in the recall, up to 8% drop when compared to the variant caller with the highest recall. 
The trade-off between precision and recall, however, needs to be evaluated on a case-by-




 Future versions of NeST, however, need to address the issue of consensus InDel 
calling. The main bottleneck with regard is the difference in the representation of InDels 
by the various methods. One possible solution discussed in the previous section was 
unfurling InDel calls and locally assembling the consensus calls, the computational burden 
of this proposed solution needs to be evaluated further.  
 Through my Ph.D. thesis work, I aimed to advance the utilization of NGS 
technology in the public health sector. The solutions offered in this thesis provide an 
efficient and scalable framework for genomic clustering and molecular surveillance of drug 
resistance in malaria. The utility of NGS analysis methods that I developed is demonstrated 
by their adaptation as standard protocols by the Malaria Branch at the Centers for Disease 
Control and Prevention. Considering the standardization and improved accuracy, I hope 
that public health labs across the world adopt the solutions described in the present work 
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